Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.363676582728644e-23,9.302712857894342,478.9607968977353,"['RPL4', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL8', 'RPL9', 'RPL7', 'RPS4X', 'RPS15', 'RPS14', 'RPS6KA6', 'RPS16', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS10', 'RPS12', 'RPS9', 'RPS7', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL12', 'MRPL19', 'RPL36A', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS6KB1', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24']",2.3258396185943673e-20,0,0,52
2,Regulation of Microtubule Cytoskeleton WP2038,4.831058638235483e-05,4.100499053519187,40.750184874336334,"['GSK3B', 'TRIO', 'ROCK1', 'PRKCA', 'TIAM1', 'CLIP1', 'APC', 'CFL2', 'TAOK1', 'CAMK4', 'GNAQ', 'STMN1', 'ABL1', 'CLASP1', 'MARK2', 'MARK1']",0.010257835140581404,0,0,16
3,Nonalcoholic fatty liver disease WP4396,5.773640792072085e-05,2.3241896240483477,22.683213574445503,"['GSK3B', 'COX7B', 'PRKAA1', 'NDUFB8', 'NDUFA11', 'NDUFB10', 'COX4I1', 'NDUFB4', 'NDUFB3', 'PIK3R3', 'NDUFB1', 'UQCR11', 'PIK3CB', 'ADIPOR1', 'COX5B', 'COX7A1', 'UQCRH', 'MAPK8', 'MLX', 'CYC1', 'MAP3K5', 'COX8A', 'TGFB1', 'NDUFA4', 'INSR', 'NDUFA3', 'COX6C', 'MLXIPL', 'ITCH', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'NDUFS4', 'CYCS', 'PPARA']",0.010257835140581404,0,0,35
4,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.00010361887288958217,2.62705130713672,24.102646883608372,"['COX7B', 'NDUFB8', 'NDUFB10', 'COX4I1', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC3', 'NDUFB1', 'UQCR11', 'COX5B', 'COX7A1', 'UQCRH', 'SLC25A27', 'ATP5ME', 'COX8A', 'SURF1', 'NDUFA4', 'NDUFA3', 'COX6C', 'ATP5F1E', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'NDUFS4', 'ATP5PO']",0.013807214812536824,0,0,26
5,Endoderm differentiation WP2853,0.0001671346747102011,2.3418708900254743,20.366573475436017,"['NR3C1', 'FOXO1', 'ACACA', 'CDC73', 'MBTD1', 'CAND1', 'UBR5', 'JARID2', 'BPTF', 'MAP2K3', 'SMAD2', 'VAV3', 'TGFB1', 'PBX3', 'CDYL', 'EMSY', 'PIAS1', 'NME1', 'EXT1', 'TNRC6C', 'TOX3', 'DDAH1', 'APC', 'RFX7', 'SP4', 'NABP2', 'TCF4', 'WDFY2', 'NAA15', 'BMPR1A']",0.01488595468449106,0,0,30
6,EGF/EGFR signaling pathway WP437,0.00016757172252710386,2.0952443118239463,18.21626169441749,"['ATF1', 'ROCK1', 'SH3KBP1', 'CBL', 'FOXO1', 'EGFR', 'ATXN2', 'MAPK8', 'RAP1A', 'RPS6KA2', 'STMN1', 'ABL1', 'NCK2', 'AP2S1', 'PLCE1', 'MAPK1', 'JAK2', 'HRAS', 'MAP3K4', 'AP2M1', 'MEF2A', 'VAV3', 'USP8', 'STAT5B', 'MEF2C', 'MAP3K1', 'PRKCA', 'GAB2', 'PTPN12', 'PTK2', 'EPN1', 'ITCH', 'CREB1', 'RPS6KB1', 'SOS1', 'STAM2', 'SOS2', 'ARF6']",0.01488595468449106,0,0,38
7,Pathways affected in adenoid cystic carcinoma WP3651,0.00029921200430619373,2.9222078593588416,23.711841280341428,"['SETD2', 'CREBBP', 'FBXW7', 'CNTN6', 'KMT2C', 'ATRX', 'ERBIN', 'JMJD1C', 'ARID4B', 'FOXP2', 'NCOR1', 'NFIB', 'KAT6A', 'NSD1', 'EP300', 'TLK1', 'ATM', 'MAML3', 'HRAS']",0.022782856899314464,0,0,19
8,TGF-beta Signaling Pathway WP366,0.0003909732805823797,2.2015452046653294,17.275241962322095,"['ROCK1', 'ZFYVE9', 'HDAC1', 'MAPK8', 'PRKAR2A', 'EP300', 'MAPK1', 'BTRC', 'MAP3K7', 'SPTBN1', 'PDK1', 'MEF2A', 'MAP2K3', 'SMAD2', 'MAP2K4', 'MEF2C', 'CREBBP', 'TGFB1', 'SMURF2', 'SMURF1', 'NUP153', 'PIAS2', 'PTK2', 'PIAS1', 'ZEB2', 'ITCH', 'ZFYVE16', 'RBL1', 'ZEB1', 'SOS1']",0.026048594818801046,0,0,30
9,MECP2 and Associated Rett Syndrome WP3584,0.0013994469616736356,2.485522233712513,16.33405214911176,"['MEF2C', 'RBFOX1', 'GRID1', 'HDAC1', 'DLX6', 'GAD1', 'RPS6', 'TET2', 'GABRR2', 'FUT8', 'CREB1', 'NCOR1', 'SP3', 'NF1', 'SGK1', 'GRIA3', 'CDON', 'FKBP5', 'GRIA4']",0.08287835895244976,0,0,19
10,Leptin signaling pathway WP2034,0.0024684167286029555,2.3358014477766287,14.024568446285967,"['GSK3B', 'STAT5B', 'PRKAA1', 'ROCK1', 'ROCK2', 'RPS6', 'FOXO1', 'ACACA', 'PTK2', 'SOCS2', 'MAPK8', 'CREB1', 'RPS6KB1', 'CFL2', 'MAPK1', 'FYN', 'JAK2', 'SOS1', 'HRAS']",0.11435034731046148,0,0,19
11,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.002486298167389898,1.9586776859504131,11.746112429836504,"['GSK3B', 'PRKAA1', 'PIK3R3', 'PIK3CB', 'CBL', 'FOXO1', 'RPTOR', 'RPS6KA6', 'MAPK8', 'SESN3', 'RPS6KA2', 'MAPK1', 'MAP3K9', 'MAP3K7', 'HRAS', 'MAP3K4', 'MAP4K3', 'MAP3K5', 'MAP4K4', 'MAP2K3', 'MAP2K4', 'MAP3K1', 'INSR', 'MLXIPL', 'RPS6KB1', 'MAP3K10', 'SOS1', 'SOS2']",0.11435034731046148,0,0,28
12,Energy Metabolism WP1541,0.002613495696351152,2.7732619075346454,16.49277328141117,"['MEF2A', 'GSK3B', 'PRKAA1', 'MEF2C', 'HDAC1', 'NRF1', 'FOXO1', 'PPP3CC', 'PPP3R2', 'CREB1', 'CAMK4', 'EP300', 'PPARA', 'PPARGC1A']",0.11435034731046148,0,0,14
13,Mitochondrial CIV Assembly WP4922,0.0030956093392321142,3.2143347555294004,18.5716885714496,"['COX8A', 'COX7B', 'SURF1', 'NDUFA4', 'COX4I1', 'COX17', 'CMC1', 'COX5B', 'COX6C', 'COX10', 'COX20']",0.11435034731046148,0,0,11
14,ErbB signaling pathway WP673,0.003245425725932582,2.1137687726566545,12.112970432387419,"['GSK3B', 'MAP2K4', 'STAT5B', 'PIK3R3', 'PRKCA', 'PIK3CB', 'NRG2', 'CBL', 'FOXO1', 'EGFR', 'PTK2', 'MAPK8', 'RPS6KB1', 'NCK2', 'ABL1', 'MAPK1', 'ABL2', 'SOS1', 'PAK3', 'HRAS', 'SOS2', 'PAK5']",0.11435034731046148,0,0,22
15,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.003279235326392606,2.6863718411552346,15.366436498207452,"['GSK3B', 'PRKAA1', 'PIK3R3', 'PIK3CB', 'CACNA1C', 'GRIN2B', 'GRM1', 'RPTOR', 'GRIN2A', 'RPS6KB1', 'CAMK4', 'NF1', 'MAPK1', 'HRAS']",0.11435034731046148,0,0,14
16,Oxidative phosphorylation WP623,0.003432655829207099,2.5589095287237704,14.520330026220996,"['NDUFB8', 'NDUFA11', 'NDUFB10', 'NDUFA4', 'NDUFB4', 'NDUFA3', 'ATP6AP2', 'ATP5MC3', 'NDUFB1', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFS4', 'ATP5PO', 'ATP5ME']",0.11435034731046148,0,0,15
17,Chemokine signaling pathway WP3929,0.0046941067868879905,1.904045271455754,10.208438631354262,"['GSK3B', 'ROCK1', 'ROCK2', 'GNAI3', 'PIK3R3', 'PIK3CB', 'RASGRP2', 'CX3CL1', 'ADCY5', 'GNG3', 'RAP1A', 'GRK5', 'MAPK1', 'JAK2', 'HRAS', 'VAV3', 'STAT5B', 'PTK2', 'TIAM2', 'TIAM1', 'HCK', 'ADCY9', 'PLCB4', 'ELMO1', 'SOS1', 'SOS2']",0.1388654611262678,0,0,26
18,Pathways in clear cell renal cell carcinoma WP4018,0.00488766544405778,2.1620513999004176,11.504363070161045,"['SETD2', 'PBRM1', 'CREBBP', 'TGFB1', 'KSR1', 'ARNT', 'ENO2', 'ACACA', 'EGFR', 'RPTOR', 'ACLY', 'PKM', 'ZEB1', 'EP300', 'ALDOC', 'ENPP3', 'CEP290', 'PSPH', 'PFKP']",0.1388654611262678,0,0,19
19,Male infertility WP4673,0.00506927171911648,2.018612272660519,10.667473870244368,"['USP8', 'SLC46A1', 'CREBBP', 'PACRG', 'CCNT2', 'ABCB1', 'INSR', 'CXXC1', 'PEX10', 'AHR', 'TEX15', 'CHD2', 'CDC42BPA', 'PUM2', 'ABLIM1', 'EP300', 'SLC16A7', 'HLA-DRA', 'ATM', 'RGS9', 'CLOCK', 'SOX5']",0.1388654611262678,0,0,22
20,PKC-gamma calcium signaling pathway in ataxia WP4760,0.0055596379432473145,3.772987937512359,19.5901920726783,"['GRIA2', 'PLCB4', 'GNAQ', 'ATP2B2', 'GRM1', 'GRIA3', 'PDK1', 'GRIA4']",0.1388654611262678,0,0,8
21,Common Pathways Underlying Drug Addiction WP2636,0.005706389351116937,2.7273455836052434,14.089927642107742,"['GRIA2', 'PPP1CC', 'GRIN2A', 'RAP1A', 'CREB1', 'CAMK4', 'MAPK1', 'PRKCA', 'DRD1', 'GRM1', 'GRIA3', 'GRIA4']",0.1388654611262678,0,0,12
22,Circadian rhythm related genes WP3594,0.005875762021741994,1.7216631355932204,8.844044970735222,"['GSK3B', 'NLGN1', 'PRKAA1', 'PHLPP1', 'ROCK2', 'HDAC1', 'RORA', 'AHR', 'RORB', 'PPP1CC', 'MAPK8', 'EP300', 'DRD1', 'BTRC', 'PPARGC1A', 'CHRNB2', 'OPN3', 'FBXW11', 'KCNH7', 'NTRK3', 'DYRK1A', 'ARNT', 'BTBD9', 'NCOR1', 'PER3', 'CREB1', 'ADORA2A', 'PSPC1', 'GNAQ', 'PPARA', 'CLOCK', 'UBA52', 'LGR4']",0.1388654611262678,0,0,33
23,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.005992318209951518,2.5738443631526438,13.171074376795836,"['MAP2K3', 'MAP2K4', 'RPS6', 'PIK3R3', 'PRKCA', 'PIK3CB', 'RPTOR', 'MAPK8', 'RPS6KB1', 'RPS6KA2', 'MAPK1', 'PIM2', 'PDK1']",0.1388654611262678,0,0,13
24,Joubert Syndrome WP4656,0.006934413406197336,2.1262969588550984,10.570372496476619,"['CEP120', 'ARMC9', 'MYO5A', 'CPLANE1', 'RPGRIP1L', 'AHI1', 'NIN', 'TMEM17', 'KIAA0586', 'TMEM237', 'SUFU', 'TMEM67', 'MYO6', 'INPP5E', 'NPHP4', 'ATM', 'CEP290', 'PIBF1']",0.15201191719539334,0,0,18
25,IL-3 signaling pathway WP286,0.007130014877832708,2.6297195848973285,12.999866133507435,"['HCK', 'STAT5B', 'MAPK8', 'TGFB1', 'MAPK1', 'FYN', 'ENPP3', 'GAB2', 'JAK2', 'SOS1', 'CBL', 'HRAS']",0.15201191719539334,0,0,12
26,Gastrin signaling pathway WP4659,0.009336308745055909,1.8600081810744478,8.69338866141697,"['GSK3B', 'MEF2C', 'YES1', 'ROCK1', 'PRKCE', 'RPS6', 'PIK3R3', 'PRKCA', 'CLDN1', 'FOXO1', 'PTK2', 'EGFR', 'TJP1', 'MAPK8', 'CREB1', 'RPS6KB1', 'GNAQ', 'MAPK1', 'TCF4', 'FYN', 'JAK2', 'SOS1', 'HRAS']",0.18803414950896924,0,0,23
27,Prolactin Signaling Pathway WP2037,0.009819725219830116,2.0877685950413225,9.652510276669705,"['GSK3B', 'STAT5B', 'RPS6', 'PIK3CB', 'GAB2', 'CBL', 'PTK2', 'SOCS2', 'MAPK8', 'RPS6KB1', 'RPS6KA2', 'IRF1', 'MAPK1', 'FYN', 'JAK2', 'SOS1', 'HRAS']",0.18803414950896924,0,0,17
28,Mesodermal commitment pathway WP2857,0.009877966578332344,1.8212468559798782,8.409513745970962,"['SMAD2', 'VAV3', 'MACF1', 'SETD2', 'BMPR2', 'PBX3', 'EMSY', 'ACACA', 'PIAS1', 'MBTD1', 'EXT1', 'LATS1', 'CCDC88A', 'TOX3', 'DDAH1', 'UBR5', 'NABP2', 'RARB', 'RPL38', 'TCF4', 'WDFY2', 'JAK2', 'JARID2', 'BMPR1A']",0.18803414950896924,0,0,24
29,Sleep regulation WP3591,0.010345934557593627,3.269374464438732,14.944839115108923,"['CHRNB2', 'CACNA1I', 'NLGN1', 'GRIN2A', 'PER3', 'ADORA2A', 'DRD1', 'BTBD9']",0.19015114204128977,0,0,8
30,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.011523339440095693,3.574940047961631,15.956318713199227,"['CREB1', 'RPS6KB1', 'RPS6', 'MAPK1', 'PRKCA', 'SGK1', 'FOXO1']",0.1979230171644735,0,0,7
31,TNF-alpha signaling pathway WP231,0.011884287702634772,1.9448638400551534,8.62068309453644,"['MAP2K3', 'MAP2K4', 'CREBBP', 'MAP3K1', 'KSR1', 'FBXW11', 'OTUD7B', 'KSR2', 'MAPK8', 'TBK1', 'CDC37', 'MAPK1', 'FADD', 'BTRC', 'SOS1', 'NFKBIE', 'MAP3K7', 'HRAS', 'MAP3K5']",0.1979230171644735,0,0,19
32,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.012306651298163053,4.0845745591508305,17.96238801159141,"['TJP1', 'CREB1', 'MAPK1', 'LPP', 'PTK2', 'VCL']",0.1979230171644735,0,0,6
33,Insulin Signaling WP481,0.012445123775273709,1.6437708565072302,7.210279876307294,"['GSK3B', 'PRKAA1', 'PIK3R3', 'PIK3CB', 'CBL', 'FOXO1', 'CYTH3', 'RPS6KA6', 'MAPK8', 'RPS6KA2', 'MAPK1', 'MAP3K9', 'MAP3K7', 'GYG1', 'HRAS', 'MAP3K4', 'MAP4K3', 'MAP3K5', 'MAP4K4', 'MAP2K3', 'MAP2K4', 'MAP3K1', 'INSR', 'PRKCA', 'INPP4A', 'RPS6KB1', 'MAP3K10', 'SOS1', 'SGK1', 'SOS2', 'ARF6']",0.1979230171644735,0,0,31
34,IL-6 signaling pathway WP364,0.012996821014552669,2.498779417934928,10.852325172382793,"['GSK3B', 'MAP2K4', 'HCK', 'CREBBP', 'RPS6KB1', 'HDAC1', 'IRF1', 'MAPK1', 'JAK2', 'SOS1', 'MAP3K7']",0.1979230171644735,0,0,11
35,Interleukin-11 Signaling Pathway WP2332,0.012996821014552669,2.498779417934928,10.852325172382793,"['ATF1', 'TGFB1', 'YES1', 'CREB1', 'RPS6KB1', 'RPS6', 'MAPK1', 'FYN', 'JAK2', 'HRAS', 'PIAS1']",0.1979230171644735,0,0,11
36,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.01447214423705472,1.7263333954962936,7.31193613447991,"['GSK3B', 'TUSC3', 'EIF5A2', 'PIK3R3', 'PIK3CB', 'NR2C2', 'CLDN1', 'PKD1', 'LRP6', 'MAPK8', 'MAPK1', 'HRAS', 'MAP2K3', 'SMAD2', 'MAP2K4', 'TGFB1', 'EED', 'NUBPL', 'TJP1', 'ZEB2', 'ZEB1', 'COL4A2', 'CTDSP1', 'SOS1', 'SOS2']",0.21426813550972684,0,0,25
37,Fragile X Syndrome  WP4549,0.016095026677463865,1.7070078377132318,7.048653504980477,"['CYFIP1', 'GRIA2', 'ABCD3', 'PIK3CB', 'GRM1', 'RPTOR', 'GRIN2A', 'MKNK1', 'AP2S1', 'MAPK1', 'FYN', 'AP2M1', 'PDK1', 'EPHA4', 'GAD1', 'PRKCA', 'DICER1', 'GRIN2B', 'TARBP2', 'DNM2', 'CREB1', 'RPS6KB1', 'CAMK4', 'NF1', 'SOS1']",0.23185538429968217,0,0,25
38,Transcription factor regulation in adipogenesis WP3599,0.017389673112760174,3.675808936825886,14.89393211363724,"['MAPK8', 'CREB1', 'INSR', 'NR3C1', 'PPARGC1A', 'FOXO1']",0.23216560491050897,0,0,6
39,Non-small cell lung cancer WP4255,0.01749090532561924,1.9324686256504437,7.818911504247802,"['ALK', 'RB1', 'STAT5B', 'PIK3R3', 'PRKCA', 'PIK3CB', 'FHIT', 'EGFR', 'EML4', 'CDK6', 'RARB', 'MAPK1', 'CYCS', 'SOS1', 'HRAS', 'SOS2', 'PDK1']",0.23216560491050897,0,0,17
40,Androgen receptor signaling pathway WP138,0.017569145080797138,1.851783457264326,7.484188456904828,"['RB1', 'GSK3B', 'CREBBP', 'ROCK1', 'ROCK2', 'HDAC1', 'NR2C2', 'PIAS2', 'FOXO1', 'EGFR', 'PTK2', 'PIAS1', 'KAT2B', 'CREB1', 'NCOR1', 'ZNF318', 'BAG1', 'EP300', 'RAD9A']",0.23216560491050897,0,0,19
41,Hepatitis B infection WP4666,0.017858892685423768,1.688107017463864,6.795059026739785,"['PIK3R3', 'PIK3CB', 'MAPK8', 'TBK1', 'EP300', 'MAPK1', 'FADD', 'JAK2', 'MAP3K7', 'HRAS', 'MAP2K3', 'SMAD2', 'MAP2K4', 'STAT5B', 'CREBBP', 'TICAM2', 'TGFB1', 'MAP3K1', 'PRKCA', 'CREB1', 'TRAF3', 'CYCS', 'SOS1', 'SOS2', 'TLR4']",0.23216560491050897,0,0,25
42,Kit receptor signaling pathway WP304,0.018310543614481,2.1553775424909447,8.622109863353502,"['STAT5B', 'RPS6', 'PRKCA', 'GAB2', 'CBL', 'MAPK8', 'RPS6KB1', 'EP300', 'MAPK1', 'FYN', 'JAK2', 'SOS1', 'HRAS']",0.23236951777424697,0,0,13
43,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.018999994616906355,1.6236020583190394,6.434848962150331,"['CYFIP1', 'GRIA2', 'GSK3B', 'PRKAA1', 'DOCK3', 'MAPK8', 'RAP1A', 'NCK2', 'MAPK1', 'FYN', 'JAK2', 'HRAS', 'GRIA3', 'MEF2A', 'VAV3', 'STAT5B', 'MEF2C', 'MAP3K1', 'KSR1', 'NTRK3', 'RPS6', 'RANBP9', 'GRIN2B', 'TIAM1', 'CREB1', 'RPS6KB1', 'APC', 'CAMK4']",0.2355115611816532,0,0,28
44,Ciliopathies WP4803,0.01980048864011774,1.5616205184138552,6.124751666034139,"['IFT172', 'CEP120', 'PKD2', 'PKD1', 'TTBK2', 'SUFU', 'TMEM67', 'INPP5E', 'NEK1', 'NPHP4', 'IFT57', 'PIBF1', 'CEP290', 'DNAI1', 'CEP78', 'IFT140', 'SCLT1', 'DNAAF5', 'CPLANE1', 'RPGRIP1L', 'AHI1', 'TMEM17', 'WDR60', 'TMEM237', 'NME7', 'KIAA0586', 'ALMS1', 'EFHC1', 'SPAG1', 'CCDC65', 'CCDC151', 'SDCCAG8']",0.239855919208699,0,0,32
45,ACE Inhibitor Pathway WP554,0.02223696145675445,9.181538461538462,34.944930280412265,"['TGFB1', 'ATP6AP2', 'NR3C2']",0.2633844545877805,0,0,3
46,Histone Modifications WP2369,0.022969190638217746,2.248335049776862,8.484320512977272,"['KMT2E', 'SETD5', 'SETD2', 'SETBP1', 'SETD9', 'EED', 'KMT2C', 'NSD1', 'EHMT1', 'ASH1L', 'SMYD3']",0.2643827789060221,0,0,11
47,G13 Signaling Pathway WP524,0.023313303205596693,2.3579714161289047,8.862980561474226,"['GNA13', 'CYFIP1', 'ROCK1', 'RPS6KB1', 'ROCK2', 'CFL2', 'PIP4K2A', 'PIK3CB', 'PAK3', 'MAP3K4']",0.2643827789060221,0,0,10
48,Airway smooth muscle cell contraction WP4962,0.026416355327217318,3.8276437371663246,13.908784411045199,"['RYR1', 'PPP1R14A', 'ROCK1', 'ROCK2', 'GNAQ']",0.28540548419257655,0,0,5
49,Type II diabetes mellitus WP1584,0.026416355327217318,3.8276437371663246,13.908784411045199,"['SURF1', 'MAPK8', 'INSR', 'MAPK1', 'PHKA2']",0.28540548419257655,0,0,5
50,Biotin Metabolism (including IEMs) WP5031,0.027253099081874756,4.8981015905592615,17.645842192024762,"['PC', 'PCCA', 'HLCS', 'ACACA']",0.28540548419257655,0,0,4
51,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.028055641972714068,2.5802191854958734,9.220582334403865,"['RPTOR', 'GSK3B', 'TFEB', 'PIK3R3', 'PIK3CB', 'HRAS', 'FOXO1', 'PDK1']",0.28540548419257655,0,0,8
52,IL-2 signaling pathway WP49,0.028379907433783408,2.3983494363929148,8.543097855929403,"['STAT5B', 'RPS6KB1', 'RPS6', 'MAPK1', 'FYN', 'GAB2', 'CBL', 'SOS1', 'HRAS']",0.28540548419257655,0,0,9
53,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.028379907433783408,2.3983494363929148,8.543097855929403,"['STAT5B', 'HCK', 'MAPK8', 'YES1', 'RPS6', 'MAPK1', 'FYN', 'GAB2', 'JAK2']",0.28540548419257655,0,0,9
54,Rett syndrome causing genes WP4312,0.030687678362658902,2.043963592649837,7.120952621780928,"['KDM5B', 'GRIN2A', 'MEF2C', 'NCOR1', 'TRRAP', 'HDAC1', 'TBL1XR1', 'SATB2', 'TCF4', 'HAP1', 'SMARCA1', 'GRIN2B']",0.3028987512462443,0,0,12
55,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.03215808729307386,2.1074600926879508,7.24353277318981,"['SMAD2', 'TGFB1', 'ADCY9', 'MAPK1', 'MAP3K9', 'SOS1', 'HRAS', 'SOS2', 'SYNE1', 'ADCY5', 'PLEC']",0.31164110049469756,0,0,11
56,MAPK Signaling Pathway WP382,0.03278192185071608,1.4275451559934318,4.87917529491893,"['CACNA1B', 'CACNA1C', 'RASGRP2', 'RASGRP1', 'EGFR', 'CACNA1I', 'CACNG7', 'MAPK8', 'PPP3R2', 'PPP3CC', 'RAP1A', 'MKNK1', 'STMN1', 'MAPK1', 'FLNB', 'FLNC', 'CACNG2', 'HRAS', 'MAP3K7', 'MAP4K3', 'MAP3K4', 'MAP4K4', 'MAP3K5', 'MAP2K3', 'MAP2K4', 'MEF2C', 'MAP3K1', 'TGFB1', 'CACNA2D2', 'PRKCA', 'CACNB2', 'PPM1B', 'FGF14', 'TAOK3', 'TAOK1', 'RASA2', 'NF1', 'SOS1', 'SOS2']",0.31201364904342266,0,0,39
57,ERK Pathway in Huntington's Disease WP3853,0.03644496261939848,3.4020647958019623,11.267475406035773,"['CREB1', 'MAPK1', 'HRAS', 'GRM1', 'EGFR']",0.315802342180422,0,0,5
58,Transcription co-factors SKI and SKIL protein partners WP4533,0.03644496261939848,3.4020647958019623,11.267475406035773,"['LATS1', 'HDAC1', 'SATB2', 'NF1', 'MERTK']",0.315802342180422,0,0,5
59,Ras signaling WP4223,0.03801537286149542,1.4970168940757176,4.894892923810743,"['PIK3R3', 'PIK3CB', 'RASGRP2', 'RASGRP1', 'EGFR', 'GRIN2A', 'GNG3', 'MAPK8', 'RAP1A', 'ABL1', 'PLCE1', 'ABL2', 'MAPK1', 'SHOC2', 'PAK3', 'HRAS', 'PAK5', 'KSR1', 'INSR', 'PRKCA', 'KSR2', 'GAB2', 'GRIN2B', 'TIAM1', 'RASA2', 'NF1', 'SOS1', 'SOS2', 'ARF6']",0.315802342180422,0,0,29
60,DNA damage response (only ATM dependent) WP710,0.03888262074867619,1.665622691682671,5.408623155479582,"['GSK3B', 'TGFB1', 'MAP3K1', 'INSR', 'PIK3R3', 'PIK3CB', 'PPP2R5C', 'MAPK8', 'APC', 'PPP2R5E', 'ABL1', 'MAPK1', 'ATM', 'SOS1', 'MAP3K7', 'HRAS', 'SOS2', 'MAP3K4', 'PDK1']",0.315802342180422,0,0,19
61,Alzheimer's disease WP2059,0.039678918371906895,1.7526366251198466,5.655644916046947,"['GSK3B', 'ADAM10', 'IDE', 'CACNA1C', 'HSD17B10', 'GRIN2B', 'GRIN2A', 'PPP3CC', 'PLCB4', 'PPP3R2', 'GNAQ', 'MAPK1', 'CYCS', 'FADD', 'APOE', 'ATF6']",0.315802342180422,0,0,16
62,Insulin signaling in adipocytes (diabetic condition) WP3635,0.03986447261375877,6.12051282051282,19.72194339204315,"['RPS6KB1', 'INSR', 'RPS6']",0.315802342180422,0,0,3
63,Insulin signaling in adipocytes (normal condition) WP3634,0.03986447261375877,6.12051282051282,19.72194339204315,"['RPS6KB1', 'INSR', 'RPS6']",0.315802342180422,0,0,3
64,miRNA Biogenesis WP2338,0.03986447261375877,6.12051282051282,19.72194339204315,"['DROSHA', 'DICER1', 'TARBP2']",0.315802342180422,0,0,3
65,15q13.3 copy number variation syndrome WP4942,0.040462010172741286,4.081409269710963,13.090678483356326,"['KAT2B', 'CREBBP', 'OTUD7A', 'FYN']",0.315802342180422,0,0,4
66,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.0407001445814914,2.8268341827663863,9.050176446003684,"['CREBBP', 'DNMT3A', 'EP300', 'ATM', 'ZFX', 'ETV6']",0.315802342180422,0,0,6
67,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.0407001445814914,2.8268341827663863,9.050176446003684,"['ATF1', 'CREB1', 'RAP1A', 'MAPK1', 'HTR4', 'NR3C1']",0.315802342180422,0,0,6
68,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.04103410657053004,2.206111111111111,7.044888646128364,"['MAP2K3', 'MAP2K4', 'MAPK8', 'MAP3K1', 'RPS6KA2', 'MAPK1', 'MAP3K10', 'MAP3K9', 'MAP3K4']",0.315802342180422,0,0,9
69,CAMKK2  Pathway WP4874,0.04206747897712939,2.334092300159138,7.395525489303812,"['RPTOR', 'FIS1', 'CREB1', 'STIM1', 'CAMK4', 'EP300', 'MAPK1', 'ARHGEF7']",0.315802342180422,0,0,8
70,Glycolysis and Gluconeogenesis WP534,0.04206747897712939,2.334092300159138,7.395525489303812,"['PKM', 'PC', 'GOT1', 'PGAM1', 'SLC2A3', 'ALDOC', 'ENO2', 'PFKP']",0.315802342180422,0,0,8
71,PDGFR-beta pathway WP3972,0.04206747897712939,2.334092300159138,7.395525489303812,"['STAT5B', 'MAP2K4', 'MAPK8', 'MAP3K1', 'PRKCA', 'JAK2', 'SOS1', 'HRAS']",0.315802342180422,0,0,8
72,MET in type 1 papillary renal cell carcinoma WP4205,0.043923426548871436,1.8536921601534404,5.793357949392119,"['ALK', 'PIK3R3', 'PIK3CB', 'CBL', 'PTK2', 'MAPK8', 'RAP1A', 'MAPK1', 'SOS1', 'PAK3', 'HRAS', 'SOS2', 'PAK5']",0.3251553659798399,0,0,13
73,Calcium Regulation in the Cardiac Cell WP536,0.044980558128461634,1.5196838667269217,4.713337389494986,"['RYR1', 'RGS14', 'CACNA1B', 'GNAI3', 'CACNA1C', 'SLC8A1', 'ADCY5', 'RGS4', 'GNG3', 'GJC2', 'GRK5', 'PRKAR2B', 'PRKAR2A', 'ANXA6', 'RGS9', 'RGS7', 'KCNJ3', 'PRKCE', 'PRKCA', 'ATP2B2', 'ATP1B1', 'PKIB', 'ADCY9', 'GNAQ', 'CAMK4']",0.3284196915406856,0,0,25
74,Focal Adhesion WP306,0.04695971853591646,1.4425708699902249,4.41205265607196,"['GSK3B', 'LAMA5', 'ROCK1', 'ROCK2', 'PIK3R3', 'PIK3CB', 'EGFR', 'ARHGAP35', 'MYLK3', 'PPP1CC', 'MAPK8', 'RAP1A', 'PDGFD', 'MAPK1', 'FLNB', 'FYN', 'FLNC', 'PAK3', 'HRAS', 'VAV3', 'PPP1R12A', 'PRKCA', 'PARVA', 'VEGFD', 'PTK2', 'HCK', 'COL4A2', 'ITGA8', 'PPP1R12B', 'SOS1', 'VCL']",0.3382368916168037,0,0,31
75,Canonical and non-canonical TGF-B signaling WP3874,0.04851413278299995,3.0616016427104724,9.264100796130519,"['SMAD2', 'MAPK8', 'TGFB1', 'BMPR2', 'BMPR1A']",0.3402372733334076,0,0,5
76,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.04851413278299995,3.0616016427104724,9.264100796130519,"['GSK3B', 'MAP3K1', 'ROCK1', 'MAPK1', 'MAP3K4']",0.3402372733334076,0,0,5
77,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.05144946135258604,2.624697336561743,7.787884576577001,"['GSK3B', 'DYRK1A', 'FYN', 'PRKCA', 'RASGRP1', 'PDK1']",0.35613718053153715,0,0,6
78,Cell cycle WP179,0.05272281214847232,1.5732155411410456,4.629512462516402,"['RB1', 'SMAD2', 'CDKN2D', 'GSK3B', 'TGFB1', 'HDAC1', 'CDC7', 'ANAPC10', 'ANAPC11', 'ORC5', 'CDK6', 'STAG2', 'RBL1', 'TFDP2', 'CDC27', 'ORC2', 'ABL1', 'EP300', 'ATM', 'SKP2']",0.3602725496812275,0,0,20
79,Glycolysis in senescence WP5049,0.0566824190026357,3.4980576119621785,10.040443934640315,"['RB1', 'PRKAA1', 'PKM', 'ALDOC']",0.3776466166050603,0,0,4
80,Leptin Insulin Overlap WP3935,0.0566824190026357,3.4980576119621785,10.040443934640315,"['SOCS2', 'INSR', 'PIK3R3', 'JAK2']",0.3776466166050603,0,0,4
81,Wnt Signaling Pathway WP363,0.05777459131109648,1.8726684975397643,5.339364024453981,"['GSK3B', 'MAPK8', 'CDK6', 'APC', 'MAPK1', 'PRKCA', 'ROR1', 'TCF4', 'MAP3K7', 'CSNK1G1', 'LRP6']",0.3801710761582028,0,0,11
82,MAPK Cascade WP422,0.060056996952959844,2.1307700905331397,5.9927082450794975,"['MAP2K3', 'MAP2K4', 'MAP3K1', 'MAP2', 'MAPK1', 'SOS1', 'HRAS', 'SOS2']",0.385866566756551,0,0,8
83,VEGFA-VEGFR2 Signaling Pathway WP3888,0.06008803947616086,1.258336053526639,3.5383711041288026,"['GSK3B', 'TRAF3IP2', 'FAF1', 'SLC8A1', 'RPL7', 'RPLP2', 'LRRFIP2', 'HRAS', 'MAP3K5', 'MAP2K3', 'TMOD1', 'MAP2K4', 'MEF2C', 'FBXW11', 'PRKCE', 'TRPC1', 'RPS6', 'ARNT', 'RPL13A', 'ADAM10', 'PRKCA', 'EPN1', 'CREB1', 'EWSR1', 'KATNAL2', 'NUMB', 'RPL27', 'RPL26', 'ATF6', 'VCL', 'ARF6', 'PRKAA1', 'ROCK1', 'HDAC1', 'ROCK2', 'CBL', 'FOXO1', 'ACACA', 'MAPK8', 'RAP1A', 'MKNK1', 'MYO6', 'FAM120A', 'AP2S1', 'ABL1', 'DNAJB9', 'MAPK1', 'FLNB', 'FYN', 'FADD', 'BRD4', 'RBM39', 'CREBBP', 'PRRC2C', 'PDE4DIP', 'QKI', 'PTK2', 'RAB11A', 'ITCH', 'RPS6KB1', 'SPIRE1', 'PTPN9', 'CYCS', 'COPG1']",0.385866566756551,0,0,64
84,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.06266162827719877,2.7830408810901623,7.709039960807844,"['MAP2K3', 'PRKAA1', 'MKNK1', 'MAPK1', 'MAP3K5']",0.39068362120621786,0,0,5
85,Kynurenine Pathway and links to Cellular Senescence WP5044,0.06266162827719877,2.7830408810901623,7.709039960807844,"['HAAO', 'AHR', 'EIF2AK4', 'TLR4', 'FOXO1']",0.39068362120621786,0,0,5
86,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.06332600545267736,1.7323621694307485,4.780382735804234,"['SMARCAL1', 'LAMA5', 'TGFB1', 'PARVA', 'CLDN1', 'PTK2', 'CD2AP', 'LRP6', 'PLCE1', 'FYN', 'TLR4', 'VCL', 'LIMS1']",0.39068362120621786,0,0,13
87,NRF2-ARE regulation WP4357,0.0637701220355365,2.449512069851053,6.742209723843406,"['GSK3B', 'MAPK8', 'YES1', 'INSR', 'PRKCA', 'FYN']",0.39068362120621786,0,0,6
88,Interferon type I signaling pathways WP585,0.06582746219367046,1.8219027472374538,4.956883906841086,"['RPTOR', 'MAP2K3', 'CREB1', 'RAP1A', 'MAP3K1', 'RPS6KB1', 'RPS6', 'FYN', 'GAB2', 'CBL', 'PIAS1']",0.3987049698775722,0,0,11
89,Regulation of Actin Cytoskeleton WP51,0.06709122289102223,1.4581402152656946,3.939460408702986,"['NCKAP1', 'PPP1R12A', 'ROCK1', 'ROCK2', 'PIK3R3', 'PIK3CB', 'SSH2', 'ARHGAP35', 'PTK2', 'FGD1', 'EGFR', 'GNA13', 'FGF14', 'APC', 'CFL2', 'PIP4K2A', 'MAPK1', 'SOS1', 'ARHGEF7', 'PAK3', 'MYH10', 'SOS2', 'VCL', 'PAK5']",0.40179350338106573,0,0,24
90,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.06872323557019758,1.7510855965260912,4.688825725293093,"['GSK3B', 'ACTR2', 'MAP2K4', 'MAPK8', 'APC', 'ROCK2', 'MAPK1', 'SOS1', 'CBL', 'EGFR', 'PTK2', 'PFN2']",0.40699427287683676,0,0,12
91,Ectoderm Differentiation WP2858,0.0736116579284907,1.4669803886249522,3.8272812281902167,"['BCAS3', 'NLGN1', 'ELOVL4', 'SMURF1', 'C1GALT1', 'WDR44', 'SOCS2', 'TRPM2', 'AHI1', 'TOX3', 'PTPRB', 'GLB1', 'NARS2', 'ST8SIA4', 'FYN', 'NF2', 'KIFC3', 'PDE7A', 'TRIM33', 'CDON', 'ASTN1', 'BMPR1A']",0.42465897268664,0,0,22
92,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.07585374362631538,3.06054386865059,7.892984158469041,"['GSK3B', 'APC', 'TNKS', 'TCF4']",0.42465897268664,0,0,4
93,Aryl Hydrocarbon Receptor Netpath WP2586,0.07655691693764197,1.9011813537675606,4.8855052741639735,"['RB1', 'CDC37', 'NF1', 'EP300', 'MAPK1', 'ARNT', 'AHR', 'HRAS', 'EGFR']",0.42465897268664,0,0,9
94,EPO Receptor Signaling WP581,0.07767101064799285,2.296224961479199,5.8674820697818895,"['STAT5B', 'MAPK1', 'JAK2', 'SOS1', 'EPOR', 'PDK1']",0.42465897268664,0,0,6
95,MTHFR deficiency WP4288,0.07767101064799285,2.296224961479199,5.8674820697818895,"['GRIN2A', 'SGMS1', 'CHDH', 'DNMT3A', 'EHMT1', 'CYCS']",0.42465897268664,0,0,6
96,Constitutive Androstane Receptor Pathway WP2875,0.07887661969226521,2.5509069130732374,6.478973021376336,"['ABCB1', 'NCOA6', 'CYP3A5', 'PPARGC1A', 'FOXO1']",0.42465897268664,0,0,5
97,Imatinib and Chronic Myeloid Leukemia WP3640,0.07887661969226521,2.5509069130732374,6.478973021376336,"['ABCB1', 'ABL1', 'GAB2', 'PIM2', 'SKP2']",0.42465897268664,0,0,5
98,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.07887661969226521,2.5509069130732374,6.478973021376336,"['ABCA1', 'ABCB1', 'ABCD3', 'RARB', 'PPARA']",0.42465897268664,0,0,5
99,Proteoglycan biosynthesis WP4784,0.07887661969226521,2.5509069130732374,6.478973021376336,"['EXT1', 'CHSY1', 'B3GALT6', 'B4GALT7', 'PAPSS2']",0.42465897268664,0,0,5
100,Disruption of postsynaptic signaling by CNV WP4875,0.08223480275574861,1.9599794344473007,4.896374907273718,"['TJP1', 'CYFIP1', 'NLGN1', 'GRIN2A', 'NLGN4X', 'MAPK1', 'GRIN2B', 'GRM1']",0.42971715557660795,0,0,8
101,p38 MAPK Signaling Pathway WP400,0.08223480275574861,1.9599794344473007,4.896374907273718,"['MAP2K4', 'MAP3K1', 'CREB1', 'MKNK1', 'MAP3K9', 'HRAS', 'MAP3K7', 'MAP3K5']",0.42971715557660795,0,0,8
102,Type 2 papillary renal cell carcinoma WP4241,0.08223480275574861,1.9599794344473007,4.896374907273718,"['EGLN1', 'SETD2', 'CREBBP', 'TGFB1', 'CADM2', 'TFEB', 'EP300', 'ARNT']",0.42971715557660795,0,0,8
103,Mitochondrial complex I assembly model OXPHOS system WP4324,0.08401835924975481,1.7281813620639572,4.280221241992261,"['NDUFB8', 'NDUFB10', 'NDUFS6', 'NUBPL', 'NDUFS5', 'NDUFB4', 'NDUFA3', 'NDUFS4', 'NDUFB3', 'NDUFB1', 'TMEM186']",0.434774616311838,0,0,11
104,Leptin and adiponectin WP3934,0.0899424717380601,3.671692307692308,8.843583075448358,"['PRKAA1', 'ADIPOR1', 'ACACA']",0.4456514680433188,0,0,3
105,NLR Proteins WP288,0.0899424717380601,3.671692307692308,8.843583075448358,"['MAPK8', 'ERBIN', 'MAP3K7']",0.4456514680433188,0,0,3
106,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.0899424717380601,3.671692307692308,8.843583075448358,"['NKRF', 'HLA-DRA', 'FYN']",0.4456514680433188,0,0,3
107,G1 to S cell cycle control WP45,0.09416902530541384,1.6848352214212152,3.980699472847335,"['RB1', 'ORC5', 'CDKN2D', 'PRIM2', 'CREB1', 'CDK6', 'TFDP2', 'RPA3', 'ORC2', 'ATM', 'MNAT1']",0.4456514680433188,0,0,11
108,DNA Replication WP466,0.09491194631371543,1.8844374134862567,4.437483959008314,"['ORC5', 'PRIM2', 'POLD4', 'POLA1', 'RPA3', 'ORC2', 'CDC7', 'UBA52']",0.4456514680433188,0,0,8
109,Fas ligand pathway and stress induction of heat shock proteins WP314,0.09491194631371543,1.8844374134862567,4.437483959008314,"['RB1', 'MAP2K4', 'MAPK8', 'MAP3K1', 'FAF1', 'CYCS', 'FADD', 'MAP3K7']",0.4456514680433188,0,0,8
110,Acute viral myocarditis WP4298,0.09591837260926146,1.6339343980765928,3.8303633504091072,"['GSK3B', 'SGCD', 'ENDOG', 'CREB1', 'TGFB1', 'ABL1', 'MAPK1', 'ABL2', 'CYCS', 'FYN', 'SOS1', 'TLR4']",0.4456514680433188,0,0,12
111,Thermogenesis WP4321,0.09622532950899454,1.4713798449612403,3.444592407033332,"['MAP2K3', 'PRKAA1', 'SMARCD3', 'RPS6', 'ACSL4', 'ADCY5', 'RPTOR', 'RPS6KA6', 'ADCY9', 'CREB1', 'RPS6KB1', 'RPS6KA2', 'ZNF516', 'SOS1', 'PPARGC1A', 'HRAS', 'SOS2', 'MAP3K5']",0.4456514680433188,0,0,18
112,Melanoma WP4685,0.09697994912111624,1.5932371134020618,3.717422138966986,"['RB1', 'PIK3R3', 'PIK3CB', 'PREX2', 'GRIN2A', 'CREB1', 'CDK6', 'NF1', 'MAPK1', 'SOS1', 'HRAS', 'SOS2', 'VCL']",0.4456514680433188,0,0,13
113,miRNAs involvement in the immune response in sepsis WP4329,0.09710363528165832,2.3544858632127625,5.49060562219243,"['MAPK8', 'TRAF3', 'IRF1', 'MAP3K7', 'TLR4']",0.4456514680433188,0,0,5
114,"Relationship between inflammation, COX-2 and EGFR WP4483",0.09710363528165832,2.3544858632127625,5.49060562219243,"['PTGES2', 'MAPK1', 'PIK3CB', 'HRAS', 'EGFR']",0.4456514680433188,0,0,5
115,Platelet-mediated interactions with vascular and circulating cells WP4462,0.09751408218401504,6.117888262429523,14.240966274922542,"['TGFB1', 'TLR4']",0.4456514680433188,0,0,2
116,Sulindac Metabolic Pathway WP2542,0.09751408218401504,6.117888262429523,14.240966274922542,"['MSRA', 'MSRB3']",0.4456514680433188,0,0,2
117,miRNAs involved in DNA damage response WP1545,0.09782593200950901,2.7202554016304656,6.323412085278072,"['CREB1', 'CDK6', 'ABL1', 'ATM']",0.4456514680433188,0,0,4
118,Splicing factor NOVA regulated synaptic proteins WP4148,0.09971538603652072,1.778225806451613,4.099584528823859,"['PLCB4', 'EPB41L3', 'CASK', 'GRIK2', 'ANK3', 'STX2', 'NEO1', 'GRIN2B', 'CLASP1']",0.45040932845309783,0,0,9
119,Melatonin metabolism and effects WP3298,0.10247582887596299,1.948332243296272,4.43855086812649,"['GSK3B', 'PER3', 'MAP2', 'PRKCA', 'APOE', 'CLOCK', 'FOXO1']",0.45516347325740225,0,0,7
120,Prion disease pathway WP3995,0.10247582887596299,1.948332243296272,4.43855086812649,"['MEF2C', 'CREB1', 'EP300', 'MAPK1', 'FYN', 'CHD2', 'PTK2']",0.45516347325740225,0,0,7
121,Integrin-mediated Cell Adhesion WP185,0.11504810811506953,1.4635341619214202,3.16475345280297,"['MAP2K3', 'VAV3', 'ROCK1', 'ROCK2', 'PTK2', 'RAP1A', 'ITGA8', 'CAPN3', 'MAPK1', 'FYN', 'SOS1', 'ARHGEF7', 'PAK3', 'HRAS', 'VCL', 'TNS1']",0.506782162192827,0,0,16
122,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.11724774904313186,2.1861249633323556,4.685884683172245,"['EGLN1', 'PRKAA1', 'RPS6', 'ACACA', 'PDK1']",0.5084132753548207,0,0,5
123,BDNF-TrkB Signaling WP3676,0.11828001152720032,1.8634657491398186,3.9779412413412243,"['CREB1', 'RPS6KB1', 'MKNK1', 'MAPK1', 'GAB2', 'SOS1', 'HRAS']",0.5084132753548207,0,0,7
124,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.11828001152720032,1.8634657491398186,3.9779412413412243,"['PLCB4', 'PRKCE', 'MAPK1', 'PRKCA', 'PIK3CB', 'HRAS', 'PDK1']",0.5084132753548207,0,0,7
125,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.12237833288648574,2.4480246280143665,5.142413420167924,"['SORBS2', 'PDLIM5', 'TLR4', 'EGFR']",0.5218212114279752,0,0,4
126,Hedgehog Signaling Pathway WP4249,0.1233809875977777,1.7495409474843922,3.6608763813409273,"['CSNK1G3', 'GRK3', 'SMURF2', 'SMURF1', 'HHIP', 'SUFU', 'CDON', 'CSNK1G1']",0.5219211618223454,0,0,8
127,Phosphodiesterases in neuronal function WP4222,0.12813198225723554,1.6117235961752039,3.311599503671214,"['GUCY1A2', 'GUCY1A1', 'GRIN2A', 'CREB1', 'ADCY9', 'ADORA2A', 'DRD1', 'PDE7A', 'GRIN2B', 'ADCY5']",0.528156735065041,0,0,10
128,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.12813198225723554,1.6117235961752039,3.311599503671214,"['RB1', 'SMAD2', 'GSK3B', 'KAT2B', 'CREBBP', 'TGFB1', 'APC', 'HDAC1', 'DICER1', 'TARBP2']",0.528156735065041,0,0,10
129,Aryl Hydrocarbon Receptor Pathway WP2873,0.1285630936457907,1.933176546914281,3.9655936668805287,"['TGFB1', 'CDC37', 'EP300', 'ARNT', 'AHR', 'EGFR']",0.528156735065041,0,0,6
130,Oncostatin M Signaling Pathway WP2374,0.1288187158695222,1.5668933968816612,3.2111116766153702,"['STAT5B', 'MAPK8', 'CREB1', 'PRKCE', 'RPS6', 'MAPK1', 'PRKCA', 'LIFR', 'JAK2', 'SOS1', 'HRAS']",0.528156735065041,0,0,11
131,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.13644293832725007,1.436000386996904,2.860295627521515,"['GSK3B', 'RPS6', 'PIK3R3', 'PRKCA', 'PIK3CB', 'NRG2', 'EGFR', 'RPS6KB1', 'PDGFD', 'NF1', 'MAPK1', 'JAK2', 'SOS1', 'HRAS', 'SOS2']",0.5481726004044711,0,0,15
132,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.13911655484300903,1.6890701178973495,3.3315948230451613,"['LATS1', 'MAPK8', 'SGMS1', 'NF2', 'PAK3', 'PAK5', 'MAP4K3', 'MAP4K4']",0.5481726004044711,0,0,8
133,Zinc homeostasis WP3529,0.1391805198355959,2.0402121834360027,4.02326473078419,"['SLC39A6', 'SLC39A11', 'SLC39A12', 'SLC39A1', 'SLC39A3']",0.5481726004044711,0,0,5
134,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.14097700249441775,1.5000473141343091,2.938830453063367,"['RB1', 'MAP2K3', 'GNA13', 'CREB1', 'RAP1A', 'RPS6KB1', 'GNAQ', 'RPS6', 'GNAI3', 'MAPK1', 'JAK2', 'HRAS']",0.5481726004044711,0,0,12
135,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.14111899794416097,1.6209150326797386,3.17399766860263,"['PPP1R16B', 'PPP1CC', 'PPP1R14A', 'MAPK8', 'PPP1R13B', 'PPP1R12A', 'PPP1R9A', 'PPP1R12B', 'ATF6']",0.5481726004044711,0,0,9
136,AGE/RAGE pathway WP2324,0.14173401553323622,1.5311534500514934,2.9915723694289262,"['SMAD2', 'STAT5B', 'MAPK8', 'ROCK1', 'INSR', 'MAPK1', 'CYCS', 'PRKCA', 'JAK2', 'FOXO1', 'EGFR']",0.5481726004044711,0,0,11
137,Cardiac Hypertrophic Response WP2795,0.1418651859257919,1.5702653839555538,3.0665368280579903,"['MEF2A', 'MAP2K3', 'GSK3B', 'MAP2K4', 'MAPK8', 'TGFB1', 'MAP3K1', 'MAPK1', 'PRKCA', 'MAP3K7']",0.5481726004044711,0,0,10
138,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.14769886272069666,4.078250469844524,7.799979424743953,"['PPARA', 'CYP2C18']",0.5481726004044711,0,0,2
139,FTO Obesity Variant Mechanism WP3407,0.14769886272069666,4.078250469844524,7.799979424743953,"['FTO', 'PPARGC1A']",0.5481726004044711,0,0,2
140,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.14769886272069666,4.078250469844524,7.799979424743953,"['MAPK1', 'EGFR']",0.5481726004044711,0,0,2
141,Nanoparticle-mediated activation of receptor signaling WP2643,0.14837950252798277,1.8363636363636364,3.50374891222671,"['MAPK8', 'MAPK1', 'SOS1', 'HRAS', 'EGFR', 'PTK2']",0.5481726004044711,0,0,6
142,MAPK pathway in congenital thyroid cancer WP4928,0.14923805227434386,2.2252903586921033,4.232975318188485,"['ALK', 'KSR1', 'SOS1', 'SOS2']",0.5481726004044711,0,0,4
143,Mitochondrial complex III assembly WP4921,0.14923805227434386,2.2252903586921033,4.232975318188485,"['UQCRQ', 'UQCR11', 'CYC1', 'UQCRH']",0.5481726004044711,0,0,4
144,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.14923805227434386,2.2252903586921033,4.232975318188485,"['ABCA1', 'PRKAA1', 'PPARA', 'PPARGC1A']",0.5481726004044711,0,0,4
145,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.15336252893780047,1.7141007194244604,3.2138543269160014,"['GABRA2', 'CREB1', 'ROCK1', 'PIK3R3', 'PIK3CB', 'JAK2', 'GABRG3']",0.5481726004044711,0,0,7
146,Toll-like Receptor Signaling Pathway WP75,0.153761315139517,1.4699227202472953,2.7522153624449808,"['MAP2K3', 'MAP2K4', 'MAPK8', 'TBK1', 'TICAM2', 'TRAF3', 'PIK3R3', 'MAPK1', 'FADD', 'PIK3CB', 'MAP3K7', 'TLR4']",0.5481726004044711,0,0,12
147,Regulation of toll-like receptor signaling pathway WP1449,0.15566092418083474,1.3806161699157256,2.5680498987829203,"['MAP2K3', 'MAP2K4', 'CUEDC2', 'TICAM2', 'PELI2', 'PIK3R3', 'PIK3CB', 'MAPK8', 'TBK1', 'TRAF3', 'TIFA', 'MAPK1', 'FADD', 'ZMYND11', 'MAP3K7', 'TLR4']",0.5481726004044711,0,0,16
148,PDGF Pathway WP2526,0.1557991287028811,1.632630676949443,3.035366935216141,"['MAP2K4', 'TIAM1', 'MAPK8', 'MAP3K1', 'ARFIP2', 'MAPK1', 'SOS1', 'HRAS']",0.5481726004044711,0,0,8
149,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.15592655175381948,2.6221978021978023,4.87301426642117,"['GPRC5B', 'GRM8', 'GRM1']",0.5481726004044711,0,0,3
150,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.15592655175381948,2.6221978021978023,4.87301426642117,"['CREB1', 'MAPK1', 'PTK2']",0.5481726004044711,0,0,3
151,Neuroinflammation WP4919,0.15592655175381948,2.6221978021978023,4.87301426642117,"['MAPK8', 'ASCC1', 'TLR4']",0.5481726004044711,0,0,3
152,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.15632689542491485,1.5308800823468862,2.841016412558113,"['IFI27L2', 'MAPK8', 'PLCB4', 'PRKCE', 'SP3', 'PLCE1', 'MAPK1', 'PRKCA', 'HRAS', 'TLR4']",0.5481726004044711,0,0,10
153,Angiogenesis WP1539,0.16274627558838548,1.912538501026694,3.4723339136342917,"['CREBBP', 'ANGPT1', 'ARNT', 'MAPK1', 'PTK2']",0.5632712005753862,0,0,5
154,Toll-like Receptor Signaling related to MyD88 WP3858,0.16274627558838548,1.912538501026694,3.4723339136342917,"['TBK1', 'TICAM2', 'TRAF3', 'MAPK1', 'TLR4']",0.5632712005753862,0,0,5
155,Integrated breast cancer pathway WP1984,0.16941786161100184,1.2814130946773434,2.275004229213621,"['ATF1', 'RB1', 'SMAD2', 'USP15', 'BMPR2', 'RALGAPA1', 'HDAC1', 'NAB1', 'AHR', 'FOXO1', 'EGFR', 'PIAS1', 'RAP1A', 'CREB1', 'RASGEF1A', 'ABL1', 'NF1', 'EP300', 'MAPK1', 'ATM', 'FADD', 'FAU', 'BMPR1A']",0.571112164811323,0,0,23
156,IL17 signaling pathway WP2112,0.1694688231368645,1.7487710030082912,3.104219455180085,"['GSK3B', 'TRAF3IP2', 'TRAF3', 'MAPK1', 'JAK2', 'MAP3K7']",0.571112164811323,0,0,6
157,Oxidation by Cytochrome P450 WP43,0.1694688231368645,1.7487710030082912,3.104219455180085,"['CYB5B', 'CYP2U1', 'CYP4V2', 'CYP51A1', 'CYP3A5', 'CYP2C18']",0.571112164811323,0,0,6
158,Genes related to primary cilium development (based on CRISPR) WP4536,0.17033630772959973,1.3286634911739983,2.3517084908880364,"['IFT140', 'IFT172', 'CEP120', 'ARMC9', 'SCLT1', 'CPLANE1', 'RPGRIP1L', 'TTBK2', 'IFT88', 'TMEM17', 'WDR60', 'TMEM67', 'INPP5E', 'SASS6', 'CEP192', 'KIFAP3', 'IFT57', 'PIBF1']",0.571112164811323,0,0,18
159,G Protein Signaling Pathways WP35,0.17047804692326912,1.371355297814334,2.4261315076383845,"['PRKCE', 'GNAI3', 'PRKCA', 'ADCY5', 'GNA13', 'GNG3', 'PPP3CC', 'ADCY9', 'PRKAR2B', 'PRKAR2A', 'GNAQ', 'AKAP9', 'PDE7A', 'HRAS', 'KCNJ3']",0.571112164811323,0,0,15
160,Oxidative Damage WP3941,0.1725123049430075,1.6480354178195904,2.8960707407251984,"['MAP2K4', 'MAP3K1', 'TRAF3', 'TDP2', 'CYCS', 'MAP3K9', 'NFKBIE']",0.571112164811323,0,0,7
161,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.1725123049430075,1.6480354178195904,2.8960707407251984,"['GSK3B', 'MAPK8', 'HDAC1', 'TRAF3', 'MAPK1', 'FADD', 'MAP3K7']",0.571112164811323,0,0,7
162,Glycosaminoglycan degradation WP4815,0.17809686759963572,2.039678467590217,3.5193176795802423,"['HPSE2', 'IDUA', 'GLB1', 'ARSB']",0.5731786335460295,0,0,4
163,Methionine De Novo and Salvage Pathway WP3580,0.17809686759963572,2.039678467590217,3.5193176795802423,"['MSRA', 'CHDH', 'MSRB3', 'MAT2B']",0.5731786335460295,0,0,4
164,Pregnane X receptor pathway WP2876,0.17809686759963572,2.039678467590217,3.5193176795802423,"['ABCB1', 'CYP3A5', 'PPARGC1A', 'FOXO1']",0.5731786335460295,0,0,4
165,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.17809686759963572,2.039678467590217,3.5193176795802423,"['TGFB1', 'CDC37', 'NRF1', 'PKD1']",0.5731786335460295,0,0,4
166,Hippo-Merlin Signaling Dysregulation WP4541,0.1785134205790636,1.342564762625441,2.313361924331547,"['PPP1R14A', 'PPP1R12A', 'INSR', 'PTK2', 'EGFR', 'DCAF1', 'LATS1', 'PPP1CC', 'PLCB4', 'PRKAR2B', 'PRKAR2A', 'ITGA8', 'NF2', 'PAK3', 'HRAS', 'PAK5']",0.5731786335460295,0,0,16
167,Glioblastoma signaling pathways WP2261,0.18694719495750792,1.360953527018509,2.282222548586193,"['RB1', 'MAP2K3', 'MAP2K4', 'PRKCA', 'PIK3CB', 'CBL', 'FOXO1', 'EGFR', 'CDK6', 'NF1', 'EP300', 'MAPK1', 'ATM', 'HRAS']",0.5916395293026918,0,0,14
168,Physiological and pathological hypertrophy of the heart WP1528,0.18776841687446774,1.7998852518420099,3.010390699533531,"['MAP2K3', 'MAPK8', 'PRKCE', 'MAPK1', 'LIFR']",0.5916395293026918,0,0,5
169,Neural Crest Cell Migration during Development WP4564,0.19171636969729472,1.6691413363216137,2.7569845736858105,"['TIAM1', 'TRIO', 'PIK3R3', 'PIK3CB', 'PAK3', 'PAK5']",0.5916395293026918,0,0,6
170,ATM Signaling Pathway WP2516,0.1926309190103513,1.5868638422595258,2.6135318329345996,"['PIDD1', 'CREB1', 'CRADD', 'ABL1', 'TLK1', 'ATM', 'RAD9A']",0.5916395293026918,0,0,7
171,IL-5 signaling pathway WP127,0.1926309190103513,1.5868638422595258,2.6135318329345996,"['GSK3B', 'STAT5B', 'RPS6KB1', 'RPS6', 'MAPK1', 'JAK2', 'SOS1']",0.5916395293026918,0,0,7
172,Vitamin D-sensitive calcium signaling in depression WP4698,0.1926309190103513,1.5868638422595258,2.6135318329345996,"['GRIN2A', 'CALB1', 'KCNQ3', 'ATP2B2', 'CACNA1C', 'GRIN2B', 'SLC8A1']",0.5916395293026918,0,0,7
173,Alanine and aspartate metabolism WP106,0.19314311087930278,2.294230769230769,3.7724583889412795,"['PC', 'GOT1', 'GAD1']",0.5916395293026918,0,0,3
174,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.19314311087930278,2.294230769230769,3.7724583889412795,"['BMPR2', 'SMURF1', 'BMPR1A']",0.5916395293026918,0,0,3
175,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.20161607478672128,3.0584315735520247,4.897741767905312,"['APOE', 'TLR4']",0.6003428372140918,0,0,2
176,Cellular Proteostasis WP4918,0.20161607478672128,3.0584315735520247,4.897741767905312,"['PFDN5', 'PFDN6']",0.6003428372140918,0,0,2
177,exRNA mechanism of action and biogenesis WP2805,0.20161607478672128,3.0584315735520247,4.897741767905312,"['DROSHA', 'DICER1']",0.6003428372140918,0,0,2
178,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.20161607478672128,3.0584315735520247,4.897741767905312,"['PRKAA1', 'CTDSP1']",0.6003428372140918,0,0,2
179,Pilocytic astrocytoma WP2253,0.20161607478672128,3.0584315735520247,4.897741767905312,"['NF1', 'SOS1']",0.6003428372140918,0,0,2
180,Retinoblastoma gene in cancer WP2446,0.2053062775677868,1.349178752402586,2.136090467940674,"['RB1', 'H2AFZ', 'HDAC1', 'FAF1', 'CDC7', 'POLA1', 'ANLN', 'CDK6', 'TFDP2', 'RPA3', 'STMN1', 'ABL1', 'SKP2']",0.6079346996868353,0,0,13
181,Ebstein-Barr virus LMP1 signaling WP262,0.20862617906448452,1.8826222520424676,2.9504667642766567,"['MAPK8', 'MAPK1', 'MAP3K7', 'PDLIM7']",0.6095464098030353,0,0,4
182,Mitochondrial Gene Expression WP391,0.20862617906448452,1.8826222520424676,2.9504667642766567,"['CREB1', 'CAMK4', 'NRF1', 'PPARGC1A']",0.6095464098030353,0,0,4
183,Adipogenesis WP236,0.20983984978253614,1.285385419855117,2.0070144958583147,"['RB1', 'MEF2A', 'STAT5B', 'MEF2C', 'MBNL1', 'TGFB1', 'RORA', 'LIFR', 'AHR', 'NR3C1', 'FOXO1', 'KLF7', 'RBL1', 'CREB1', 'NCOR1', 'PPARA', 'PPARGC1A']",0.6095464098030353,0,0,17
184,Head and Neck Squamous Cell Carcinoma WP4674,0.21042502702393714,1.36058160169443,2.1206376628627566,"['RB1', 'RPTOR', 'PRKAA1', 'CDK6', 'TRAF3', 'RPS6', 'NUMB', 'PIK3CB', 'FADD', 'CSMD3', 'HRAS', 'EGFR']",0.6095464098030353,0,0,12
185,Cannabinoid receptor signaling WP3869,0.21405549070778748,1.6997490303445129,2.620197117098722,"['MAPK8', 'ADORA2A', 'PRKAR2B', 'MAPK1', 'AHR']",0.6160921572833036,0,0,5
186,Nuclear receptors WP170,0.2149965126729727,1.5964359884772559,2.4539351923757304,"['RARB', 'RORA', 'ROR1', 'NR2C2', 'NR3C1', 'PPARA']",0.6160921572833036,0,0,6
187,DNA damage response WP707,0.22079458980310562,1.3912412857343377,2.101501219930386,"['RB1', 'PIDD1', 'CREB1', 'CDK6', 'TLK2', 'ABL1', 'TLK1', 'CYCS', 'ATM', 'RAD9A']",0.6293236169254294,0,0,10
188,Pathogenic Escherichia coli infection WP2272,0.22592461200618025,1.4125118708452042,2.1011875571773637,"['ROCK1', 'ROCK2', 'NCK2', 'ABL1', 'PRKCA', 'FYN', 'ARHGEF2', 'CLDN1', 'TLR4']",0.6405203095707132,0,0,9
189,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.2322395708267093,2.039145299145299,2.9771231956536215,"['RYR1', 'TRPC1', 'GNAQ']",0.6514931118454529,0,0,3
190,FOXA2 pathway WP5066,0.2322395708267093,2.039145299145299,2.9771231956536215,"['MLXIPL', 'ACACA', 'FOXO1']",0.6514931118454529,0,0,3
191,Glycogen Synthesis and Degradation WP500,0.23541410761161266,1.477176879186306,2.136602162452917,"['GSK3B', 'PPP2R5E', 'AGL', 'PHKB', 'PPP2R5C', 'GYG1', 'PHKA2']",0.6535193716509872,0,0,7
192,NO/cGMP/PKG mediated Neuroprotection WP4008,0.23541410761161266,1.477176879186306,2.136602162452917,"['GUCY1A2', 'GRIN2A', 'GUCY1A1', 'CREB1', 'AKAP9', 'CYCS', 'GRIN2B']",0.6535193716509872,0,0,7
193,Alpha 6 Beta 4 signaling pathway WP244,0.23917563847055576,1.5297894196199282,2.188451127905803,"['LAMA5', 'MAPK1', 'PRKCA', 'SOS1', 'HRAS', 'PTK2']",0.6539849210084177,0,0,6
194,miRNA regulation of prostate cancer signaling pathways WP3981,0.23917563847055576,1.5297894196199282,2.188451127905803,"['GSK3B', 'CREBBP', 'PLCL2', 'MAPK1', 'SOS1', 'FOXO1']",0.6539849210084177,0,0,6
195,Hippo-Yap signaling pathway WP4537,0.24048976457345192,1.748002638715825,2.4910396661308507,"['LATS1', 'NF2', 'MAP4K3', 'MAP4K4']",0.6539849210084177,0,0,4
196,One-carbon metabolism WP241,0.24048976457345192,1.748002638715825,2.4910396661308507,"['CHDH', 'DNMT3A', 'GLRX', 'MAT2B']",0.6539849210084177,0,0,4
197,Corticotropin-releasing hormone signaling pathway WP2355,0.2501309899392624,1.2835716661124044,1.7787357990569572,"['GSK3B', 'TGFB1', 'PRKCA', 'ACACA', 'PTK2', 'GRK3', 'MAPK8', 'CREB1', 'GNAQ', 'MAPK1', 'TCF4', 'TLR4', 'MAP3K5']",0.6767503433382074,0,0,13
198,miRNA regulation of DNA damage response WP1530,0.2564200910590655,1.3305287654680122,1.8107674214488363,"['RB1', 'PIDD1', 'CREB1', 'CDK6', 'TLK2', 'ABL1', 'TLK1', 'CYCS', 'ATM', 'RAD9A']",0.6787189332253175,0,0,10
199,Aspirin and miRNAs WP4707,0.25722556193529855,2.4465402357765247,3.32191699552825,"['PPARA', 'PDK1']",0.6787189332253175,0,0,2
200,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.25722556193529855,2.4465402357765247,3.32191699552825,"['DROSHA', 'ATM']",0.6787189332253175,0,0,2
201,LDLRAD4 and what we know about it WP4904,0.25722556193529855,2.4465402357765247,3.32191699552825,"['SMAD2', 'LDLRAD4']",0.6787189332253175,0,0,2
202,LTF danger signal response pathway WP4478,0.25722556193529855,2.4465402357765247,3.32191699552825,"['MAPK1', 'TLR4']",0.6787189332253175,0,0,2
203,Neural Crest Cell Migration in Cancer WP4565,0.264114975759273,1.4684745762711864,1.955084107371609,"['TIAM1', 'TRIO', 'PIK3R3', 'PIK3CB', 'PAK3', 'PAK5']",0.6934644437423276,0,0,6
204,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.2696177906799691,1.529517453798768,2.0048148694255286,"['SMAD2', 'TGFB1', 'APC', 'HRAS', 'EGFR']",0.6937992494067686,0,0,5
205,Signal transduction through IL1R WP4496,0.2696177906799691,1.529517453798768,2.0048148694255286,"['MAP2K3', 'MAPK8', 'TGFB1', 'MAP3K1', 'MAP3K7']",0.6937992494067686,0,0,5
206,IL-4 signaling pathway WP395,0.2724447253793573,1.3598400457012283,1.7682265665160042,"['STAT5B', 'RPS6KB1', 'EP300', 'MAPK1', 'GAB2', 'JAK2', 'SOS1', 'CBL']",0.6937992494067686,0,0,8
207,RANKL/RANK signaling pathway WP2018,0.2724447253793573,1.3598400457012283,1.7682265665160042,"['MAPK8', 'TRAF3', 'MAPK1', 'GAB2', 'CBL', 'MAP3K7', 'PAPSS2', 'PTK2']",0.6937992494067686,0,0,8
208,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.2725636619943418,1.835076923076923,2.3853854247611506,"['GSK3B', 'HLA-DRA', 'SLC2A3']",0.6937992494067686,0,0,3
209,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.27335430089197266,1.6313323071660681,2.115816011633038,"['H2AFJ', 'H2AFZ', 'EED', 'MAPK1']",0.6937992494067686,0,0,4
210,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.27335430089197266,1.6313323071660681,2.115816011633038,"['GNAQ', 'MAPK1', 'RASGRP1', 'HRAS']",0.6937992494067686,0,0,4
211,Pyrimidine metabolism WP4022,0.28185073664884525,1.243250644329897,1.5744248303690727,"['PRIM2', 'PNPT1', 'NME2', 'NME1', 'POLD4', 'POLA1', 'NME7', 'POLR1C', 'DPYD', 'ENPP3', 'POLR2I', 'POLR2K', 'POLR2L']",0.7119736617717276,0,0,13
212,Notch Signaling Pathway Netpath WP61,0.2841486484294031,1.3112874779541446,1.6499376549408526,"['GSK3B', 'ITCH', 'NCOR1', 'FBXW7', 'HDAC1', 'NUMB', 'EP300', 'MAML3', 'JAK2']",0.7143925925135464,0,0,9
213,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.2915357763268258,1.2447541456002933,1.534274685076916,"['MAP2K3', 'GSK3B', 'MAP2K4', 'MAPK8', 'TGFB1', 'ROCK1', 'ROCK2', 'PIK3R3', 'MAPK1', 'PIK3CB', 'MYLK3', 'LRP6']",0.7240938905600987,0,0,12
214,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.29378845458197095,1.2748756218905473,1.5615891737541319,"['STAT5B', 'MAPK8', 'ANGPT1', 'STMN1', 'MAPK1', 'SOS1', 'HRAS', 'FOXO1', 'EGFR', 'PTK2']",0.7240938905600987,0,0,10
215,Prader-Willi and Angelman Syndrome WP3998,0.29397286001652556,1.3229764468839018,1.619677502145049,"['RB1', 'CYFIP1', 'GABRR2', 'SLC45A2', 'HERC2', 'CDK6', 'GNRH1', 'GABRG3']",0.7240938905600987,0,0,8
216,Cardiac Progenitor Differentiation WP2406,0.2984840468954081,1.4565610638505915,1.7610388288414713,"['GSK3B', 'MEF2C', 'TGFB1', 'THY1', 'MYLK3']",0.7240938905600987,0,0,5
217,Genes controlling nephrogenesis WP4823,0.2984840468954081,1.4565610638505915,1.7610388288414713,"['EMX2', 'NCK2', 'ITGA8', 'ETV4', 'CD2AP']",0.7240938905600987,0,0,5
218,Lipid Metabolism Pathway WP3965,0.2984840468954081,1.4565610638505915,1.7610388288414713,"['ACLY', 'PRKAA1', 'PRKAR2B', 'PRKAR2A', 'ACACA']",0.7240938905600987,0,0,5
219,White fat cell differentiation WP4149,0.2984840468954081,1.4565610638505915,1.7610388288414713,"['STAT5B', 'CREB1', 'RORA', 'NR3C1', 'FOXO1']",0.7240938905600987,0,0,5
220,Ebola Virus Pathway on Host WP4217,0.29887552706045345,1.1943034866590276,1.4423938684933848,"['CREBBP', 'TSG101', 'DAB2IP', 'PIK3R3', 'PIK3CB', 'MERTK', 'EGFR', 'TIAM1', 'TBK1', 'RASA2', 'EP300', 'HLA-DRA', 'MAPK1', 'FLNB', 'FLNC', 'TLR4']",0.7240938905600987,0,0,16
221,Metabolic reprogramming in colon cancer WP4290,0.30446300790582725,1.3383543165467626,1.5915785603389234,"['RPIA', 'ACLY', 'TIGAR', 'PKM', 'PGAM1', 'SLC16A3', 'PSPH']",0.7284540723751756,0,0,7
222,TGF-beta Receptor Signaling WP560,0.30446300790582725,1.3383543165467626,1.5915785603389234,"['SMAD2', 'ZEB2', 'CREBBP', 'TGFB1', 'ZFYVE9', 'EP300', 'HRAS']",0.7284540723751756,0,0,7
223,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.3087816740203452,1.2239052035033489,1.438236472123283,"['RPTOR', 'GSK3B', 'RPS6KA6', 'NHSL1', 'RPS6KB1', 'RPS6', 'ZNF516', 'MAPK1', 'SOS1', 'HRAS', 'PPARGC1A', 'FOXO1']",0.7284540723751756,0,0,12
224,Cell Differentiation - Index WP2029,0.3129865870453801,2.038612677259525,2.3680421751121186,"['MEF2A', 'MEF2C']",0.7284540723751756,0,0,2
225,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.3129865870453801,2.038612677259525,2.3680421751121186,"['ABCA1', 'APOE']",0.7284540723751756,0,0,2
226,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.3129865870453801,2.038612677259525,2.3680421751121186,"['MEF2A', 'MEF2C']",0.7284540723751756,0,0,2
227,Trans-sulfuration pathway WP2333,0.3129865870453801,2.038612677259525,2.3680421751121186,"['GOT1', 'MAT2B']",0.7284540723751756,0,0,2
228,Valproic acid pathway WP3871,0.3129865870453801,2.038612677259525,2.3680421751121186,"['HDAC1', 'HSD17B10']",0.7284540723751756,0,0,2
229,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.31352329252466404,1.6681118881118882,1.9348123247040736,"['SMAD2', 'TGFB1', 'MAPK1']",0.7284540723751756,0,0,3
230,PI3K-Akt signaling pathway WP4172,0.3146641892609096,1.107792483544483,1.28088425555799,"['GSK3B', 'LAMA5', 'PRKAA1', 'PHLPP1', 'PIK3R3', 'PIK3CB', 'EGFR', 'RPTOR', 'GNG3', 'PPP2R5E', 'PDGFD', 'MAPK1', 'JAK2', 'HRAS', 'ANGPT1', 'INSR', 'RPS6', 'PRKCA', 'VEGFD', 'PPP2R5C', 'PTK2', 'EPOR', 'EFNA3', 'CDK6', 'FGF14', 'CREB1', 'COL4A2', 'RPS6KB1', 'CDC37', 'PPP2R2D', 'ITGA8', 'PKN2', 'SGK1', 'SOS1', 'TLR4', 'SOS2']",0.7284540723751756,0,0,36
231,Target Of Rapamycin (TOR) Signaling WP1471,0.3157089882151324,1.3594704103178679,1.5673802196133546,"['RPTOR', 'IDI1', 'PRKAA1', 'RRAGA', 'RPS6KB1', 'PRKCA']",0.7284540723751756,0,0,6
232,T-cell receptor (TCR) signaling pathway WP69,0.320172929518499,1.2237899073120495,1.393767012569878,"['VAV3', 'MAPK8', 'CREB1', 'TGFB1', 'MAPK1', 'FYN', 'GAB2', 'SOS1', 'CBL', 'MAP3K7', 'HRAS']",0.7355697044541378,0,0,11
233,Neovascularisation processes WP4331,0.32780568406819593,1.390237072988613,1.5505790547842868,"['SMAD2', 'MAPK8', 'TGFB1', 'ANGPT1', 'MAPK1']",0.7498730884478473,0,0,5
234,Fatty Acid Biosynthesis WP357,0.3408157285816196,1.4391694081429391,1.5491411395874775,"['ACLY', 'PC', 'ACSL4', 'ACACA']",0.752856016243279,0,0,4
235,Heart Development WP1591,0.3408157285816196,1.4391694081429391,1.5491411395874775,"['MEF2C', 'BMPR2', 'MAPK1', 'BMPR1A']",0.752856016243279,0,0,4
236,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.3408157285816196,1.4391694081429391,1.5491411395874775,"['SMAD2', 'MAPK8', 'MAPK1', 'NR2C2']",0.752856016243279,0,0,4
237,IL-7 signaling pathway WP205,0.3408157285816196,1.4391694081429391,1.5491411395874775,"['GSK3B', 'STAT5B', 'MAPK1', 'FYN']",0.752856016243279,0,0,4
238,Microglia Pathogen Phagocytosis Pathway WP3937,0.3408157285816196,1.4391694081429391,1.5491411395874775,"['VAV3', 'HCK', 'PIK3R3', 'PIK3CB']",0.752856016243279,0,0,4
239,TLR4 Signaling and Tolerance WP3851,0.3408157285816196,1.4391694081429391,1.5491411395874775,"['TBK1', 'TRAF3', 'MAP3K7', 'TLR4']",0.752856016243279,0,0,4
240,Vitamin B12 metabolism WP1533,0.3408157285816196,1.4391694081429391,1.5491411395874775,"['ABCA1', 'CUBN', 'INSR', 'APOE']",0.752856016243279,0,0,4
241,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.3420828553839239,1.310807836231565,1.406106586101618,"['RPTOR', 'SMAD2', 'GSK3B', 'RPS6KB1', 'PPARGC1A', 'PDK1']",0.752856016243279,0,0,6
242,Signaling of Hepatocyte Growth Factor Receptor WP313,0.3420828553839239,1.310807836231565,1.406106586101618,"['MAPK8', 'RAP1A', 'MAPK1', 'SOS1', 'HRAS', 'PTK2']",0.752856016243279,0,0,6
243,Pathways Regulating Hippo Signaling WP4540,0.3485217551077077,1.1697240751970892,1.232953072305226,"['SMAD2', 'PRKAA1', 'PRKCE', 'INSR', 'GNAI3', 'PRKCA', 'EGFR', 'LATS1', 'PLCB4', 'PRKAR2B', 'PRKAR2A', 'GNAQ', 'NF2']",0.752856016243279,0,0,13
244,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.3496933335603882,1.1355550227763127,1.1931261843981205,"['CHRNB2', 'MEF2C', 'DLX2', 'CREBBP', 'HDAC1', 'RORA', 'NR3C1', 'CREB1', 'DEAF1', 'MAP2', 'PRKAR2B', 'PRKAR2A', 'SP3', 'EP300', 'TAC1', 'PPARGC1A', 'SPTBN1', 'CC2D1A']",0.752856016243279,0,0,18
245,Wnt signaling WP428,0.3524581175268622,1.157576348912089,1.2071477957459185,"['GSK3B', 'ROCK2', 'PRICKLE2', 'PRKCA', 'PRICKLE1', 'LRP6', 'MAPK8', 'FRAT2', 'PPP3R2', 'PPP3CC', 'PLCB4', 'APC', 'ROR1', 'MAP3K7']",0.752856016243279,0,0,14
246,"GPCRs, Other WP117",0.35252960281021706,1.2594159966144731,1.3130931636147662,"['GPR176', 'ADORA2A', 'GRM8', 'GRM1', 'CELSR3', 'ADGRL2', 'GPR135']",0.752856016243279,0,0,7
247,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.3545945942159504,1.528974358974359,1.5852102349639408,"['EED', 'STK38', 'JARID2']",0.752856016243279,0,0,3
248,GABA receptor Signaling WP4159,0.3573903113760067,1.32968038567985,1.3681437646518342,"['GABRA2', 'GAD1', 'AP2S1', 'GABRG3', 'AP2M1']",0.752856016243279,0,0,5
249,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3573903113760067,1.32968038567985,1.3681437646518342,"['ATF1', 'CAMK1D', 'CREB1', 'CAMK4', 'GNAQ']",0.752856016243279,0,0,5
250,The influence of laminopathies on Wnt signaling WP4844,0.3573903113760067,1.32968038567985,1.3681437646518342,"['GSK3B', 'CDK6', 'APC', 'DICER1', 'TARBP2']",0.752856016243279,0,0,5
251,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.36053537578927514,1.2234447300771207,1.2481157344222613,"['VAV3', 'HELLS', 'RPS6KB1', 'HDAC1', 'ABL1', 'MAPK1', 'APOE', 'PTK2']",0.752856016243279,0,0,8
252,Synaptic Vesicle Pathway WP2267,0.36053537578927514,1.2234447300771207,1.2481157344222613,"['RIMS1', 'UNC13C', 'CACNA1B', 'AP2S1', 'STX2', 'SYN2', 'AP2M1', 'DNM2']",0.752856016243279,0,0,8
253,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.36216052563374984,1.0839087198193504,1.1008911029921649,"['GSK3B', 'LAMA5', 'PRKAA1', 'PHLPP1', 'SLC2A3', 'PIK3CB', 'EGFR', 'FOXO1', 'ACACA', 'RPTOR', 'GNG3', 'PPP2R5E', 'PDGFD', 'MAPK1', 'JAK2', 'PPARGC1A', 'HRAS', 'ANGPT1', 'INSR', 'RPS6', 'VEGFD', 'PPP2R5C', 'PTK2', 'EPOR', 'RAB10', 'EFNA3', 'FGF14', 'CREB1', 'COL4A2', 'RPS6KB1', 'CDC37', 'PPP2R2D', 'ITGA8', 'SOS1']",0.752856016243279,0,0,34
254,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.3652844175217717,3.057377049180328,3.079020229724233,['TGFB1'],0.752856016243279,0,0,1
255,Nanomaterial-induced inflammasome activation WP3890,0.3652844175217717,3.057377049180328,3.079020229724233,['TLR4'],0.752856016243279,0,0,1
256,Pancreatic adenocarcinoma pathway WP4263,0.36566010528288734,1.1526744359778873,1.159649327956417,"['RB1', 'SMAD2', 'TGFB1', 'PIK3R3', 'PIK3CB', 'EGFR', 'TIAM1', 'MAPK8', 'CDK6', 'RPS6KB1', 'MAPK1', 'PAK3', 'PAK5']",0.752856016243279,0,0,13
257,3q29 copy number variation syndrome WP4906,0.3668768028716243,1.1968599033816425,1.2001263426483408,"['STAT5B', 'TGFB1', 'FBXW7', 'WDR60', 'DYNLT3', 'ADAM10', 'PIK3R3', 'RABL2B', 'NF2']",0.752856016243279,0,0,9
258,Cytokines and Inflammatory Response WP530,0.36775783424151587,1.7472358497473823,1.7478135148456098,"['TGFB1', 'HLA-DRA']",0.752856016243279,0,0,2
259,Cytosine methylation WP3585,0.36775783424151587,1.7472358497473823,1.7478135148456098,"['MBD3', 'TET2']",0.752856016243279,0,0,2
260,Farnesoid X receptor pathway WP2879,0.36775783424151587,1.7472358497473823,1.7478135148456098,"['PPARGC1A', 'FKBP5']",0.752856016243279,0,0,2
261,Netrin-UNC5B signaling pathway WP4747,0.36865932502719667,1.265501301737421,1.2628213493742977,"['ARHGEF12', 'MAPK1', 'PRKCA', 'FYN', 'NEO1', 'PTK2']",0.752856016243279,0,0,6
262,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.38705567827908205,1.2741700889801506,1.2094253335700467,"['CREBBP', 'PPP3CC', 'PPP3R2', 'HDAC1', 'EP300']",0.7874071623005753,0,0,5
263,Myometrial relaxation and contraction pathways WP289,0.3944196179745963,1.0966029931123296,1.0202135366902731,"['ATF1', 'RYR1', 'GUCY1A1', 'RGS14', 'PRKCE', 'PRKCA', 'SLC8A1', 'ADCY5', 'RGS4', 'PKIB', 'GNG3', 'ADCY9', 'CREB1', 'GRK5', 'PRKAR2B', 'PRKAR2A', 'GNAQ', 'RGS9', 'RGS7']",0.7981036233084201,0,0,19
264,Nephrotic syndrome WP4758,0.3953083612634576,1.2232152028762198,1.1352527667265138,"['SMARCAL1', 'CUBN', 'ANLN', 'PDSS2', 'PLCE1', 'CD2AP']",0.7981036233084201,0,0,6
265,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.4012603536427442,1.1892486011191048,1.0859561776838969,"['SMAD2', 'ZEB2', 'CREBBP', 'TGFB1', 'ZFYVE9', 'EP300', 'HRAS']",0.8070632773267271,0,0,7
266,Cancer immunotherapy by CTLA4 blockade WP4582,0.42071563690442837,1.5287032291132752,1.3235483822621041,"['PIK3R3', 'PIK3CB']",0.8267510087417547,0,0,2
267,miR-509-3p alteration of YAP1/ECM axis WP3967,0.42071563690442837,1.5287032291132752,1.3235483822621041,"['PBX3', 'GPC6']",0.8267510087417547,0,0,2
268,Nanoparticle triggered regulated necrosis WP2513,0.42071563690442837,1.5287032291132752,1.3235483822621041,"['MAPK8', 'FADD']",0.8267510087417547,0,0,2
269,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.42071563690442837,1.5287032291132752,1.3235483822621041,"['TIFA', 'TLR4']",0.8267510087417547,0,0,2
270,TCA cycle in senescence WP5050,0.42071563690442837,1.5287032291132752,1.3235483822621041,"['GOT1', 'PDK1']",0.8267510087417547,0,0,2
271,Copper homeostasis WP3286,0.42190670614963843,1.1836572394254188,1.0214619483382148,"['GSK3B', 'ATP7B', 'APC', 'COX17', 'ADAM10', 'FOXO1']",0.8267510087417547,0,0,6
272,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.42190670614963843,1.1836572394254188,1.0214619483382148,"['TBK1', 'TGFB1', 'TRAF3', 'CXCL17', 'EP300', 'FADD']",0.8267510087417547,0,0,6
273,IL-18 signaling pathway WP4754,0.4249112684750841,1.0587706685837528,0.9061752527111788,"['GSK3B', 'PRKAA1', 'COX17', 'RND2', 'CLDN1', 'RPTOR', 'STMN1', 'NFKBIZ', 'MAPK1', 'TRPM7', 'FADD', 'MAP3K7', 'MEF2A', 'ZNF143', 'TICAM2', 'USP5', 'FBXW7', 'PRKCA', 'GRIN2B', 'ALS2', 'RPS6KB1', 'NACA', 'IRF1', 'CYCS', 'KIFC3', 'NFKBIE', 'ARF6']",0.8295886670227832,0,0,27
274,B Cell Receptor Signaling Pathway WP23,0.43426574549158947,1.0953885902788991,0.9136621065535677,"['GSK3B', 'MEF2C', 'MAPK8', 'CREB1', 'MAPK1', 'FYN', 'GAB2', 'SOS1', 'CBL', 'MAP3K7', 'HRAS', 'FOXO1']",0.8376598480201793,0,0,12
275,Apoptosis Modulation by HSP70 WP384,0.435331665856641,1.3103296703296703,1.0897318548669606,"['MAP3K1', 'CYCS', 'FADD']",0.8376598480201793,0,0,3
276,Nanomaterial induced apoptosis WP2507,0.435331665856641,1.3103296703296703,1.0897318548669606,"['ENDOG', 'CYCS', 'FADD']",0.8376598480201793,0,0,3
277,Nucleotide metabolism WP404,0.435331665856641,1.3103296703296703,1.0897318548669606,"['POLA1', 'NME2', 'OAZ1']",0.8376598480201793,0,0,3
278,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.4459618010866886,1.1759595640499132,0.9496131937008583,"['EGLN1', 'PKM', 'ANGPT1', 'ARNT', 'SLC2A3']",0.8470994275020063,0,0,5
279,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.4498836530044183,1.1264672472548276,0.8997840509715781,"['MAP2K3', 'MAP2K4', 'MAPK8', 'MAP3K1', 'MKNK1', 'MAPK1', 'MAP3K7']",0.8470994275020063,0,0,7
280,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.45454115622058877,2.0380806010928962,1.6069589237700126,['TRAF3'],0.8470994275020063,0,0,1
281,Codeine and Morphine Metabolism WP1604,0.45454115622058877,2.0380806010928962,1.6069589237700126,['ABCB1'],0.8470994275020063,0,0,1
282,Composition of Lipid Particles WP3601,0.45454115622058877,2.0380806010928962,1.6069589237700126,['APOE'],0.8470994275020063,0,0,1
283,Gene regulatory network modelling somitogenesis  WP2854,0.45454115622058877,2.0380806010928962,1.6069589237700126,['EPHA4'],0.8470994275020063,0,0,1
284,Hypothetical Craniofacial Development Pathway WP3655,0.45454115622058877,2.0380806010928962,1.6069589237700126,['ARHGAP29'],0.8470994275020063,0,0,1
285,Macrophage markers WP4146,0.45454115622058877,2.0380806010928962,1.6069589237700126,['CD74'],0.8470994275020063,0,0,1
286,Nucleotide GPCRs WP80,0.45454115622058877,2.0380806010928962,1.6069589237700126,['ADORA2A'],0.8470994275020063,0,0,1
287,Development and heterogeneity of the ILC family WP3893,0.4712872869501944,1.3587334130645252,1.022158053575955,"['RORA', 'AHR']",0.8524132908482281,0,0,2
288,Homologous recombination WP186,0.4712872869501944,1.3587334130645252,1.022158053575955,"['POLD4', 'ATM']",0.8524132908482281,0,0,2
289,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.4712872869501944,1.3587334130645252,1.022158053575955,"['ZEB2', 'TGFB1']",0.8524132908482281,0,0,2
290,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.4712872869501944,1.3587334130645252,1.022158053575955,"['MAP3K1', 'MAPK1']",0.8524132908482281,0,0,2
291,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.4712872869501944,1.3587334130645252,1.022158053575955,"['ZEB1', 'JAK2']",0.8524132908482281,0,0,2
292,RalA downstream regulated genes WP2290,0.4712872869501944,1.3587334130645252,1.022158053575955,"['EXOC8', 'HRAS']",0.8524132908482281,0,0,2
293,RAS and bradykinin pathways in COVID-19 WP4969,0.4712872869501944,1.3587334130645252,1.022158053575955,"['ROCK1', 'MAPK1']",0.8524132908482281,0,0,2
294,Exercise-induced Circadian Regulation WP410,0.4739345962676513,1.0974912377790076,0.8194812868010365,"['NCKAP1', 'IDI1', 'ZFR', 'CLOCK', 'QKI', 'AZIN1', 'ETV6']",0.8524132908482281,0,0,7
295,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.47430002905107754,1.2228717948717949,0.9121586409174155,"['TBK1', 'TRAF3', 'TLR4']",0.8524132908482281,0,0,3
296,Vitamin D in inflammatory diseases WP4482,0.47430002905107754,1.2228717948717949,0.9121586409174155,"['MAP2K3', 'MAP3K1', 'NR3C1']",0.8524132908482281,0,0,3
297,Sphingolipid pathway WP1422,0.4749845166640221,1.1646509809670405,0.8670512935798923,"['CERS5', 'CERS6', 'SGMS1', 'SERINC1']",0.8524132908482281,0,0,4
298,7q11.23 copy number variation syndrome WP4932,0.48698639202478655,1.0458898534997287,0.7525377247758094,"['RB1', 'TSG101', 'UBE2E1', 'ATP5MC3', 'CLDN1', 'ACACA', 'ATP5F1E', 'CLIP2', 'MLXIPL', 'ATP5PO', 'GTF2IRD1', 'CLASP1', 'BRD4']",0.8710192850644671,0,0,13
299,Endometrial cancer WP4155,0.49344735231420456,1.0582264957264957,0.74746675909604,"['GSK3B', 'APC', 'PIK3R3', 'MAPK1', 'PIK3CB', 'SOS1', 'HRAS', 'SOS2', 'EGFR']",0.8796235410818428,0,0,9
300,Parkinson's disease pathway WP2371,0.5033318053220491,1.0917791141097095,0.7495125561869341,"['PRKN', 'ATXN2', 'PINK1', 'CYCS', 'UBE2G1']",0.8876399602581774,0,0,5
301,Phosphoinositides metabolism WP4971,0.5033318053220491,1.0917791141097095,0.7495125561869341,"['PLCB4', 'PIP4K2A', 'PLCE1', 'PIK3CB', 'PLCH2']",0.8876399602581774,0,0,5
302,ESC Pluripotency Pathways WP3931,0.5041145921126166,1.0322198420136564,0.7070207060926892,"['MAP2K3', 'GSK3B', 'ACTR2', 'BMPR2', 'LIFR', 'EGFR', 'LRP6', 'FGF14', 'APC', 'MAPK1', 'SOS1', 'HRAS', 'BMPR1A']",0.8876399602581774,0,0,13
303,Pre-implantation embryo WP3527,0.5070754955686249,1.1116190120807874,0.7548953354569381,"['DLX2', 'SOX11', 'ZFP36L2', 'NR3C2']",0.8876399602581774,0,0,4
304,Resistin as a regulator of inflammation WP4481,0.5070754955686249,1.1116190120807874,0.7548953354569381,"['PLCB4', 'MAPK1', 'PLCE1', 'PIK3CB']",0.8876399602581774,0,0,4
305,Immune response to tuberculosis WP4197,0.5119773338094097,1.146346153846154,0.767450005170805,"['IRF1', 'JAK2', 'PIAS1']",0.8876399602581774,0,0,3
306,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5119773338094097,1.146346153846154,0.767450005170805,"['GALNT16', 'GALNT1', 'ST6GALNAC3']",0.8876399602581774,0,0,3
307,Cell Differentiation - Index expanded WP2023,0.5190968042377451,1.2227575602255254,0.8017192043030085,"['MEF2A', 'MEF2C']",0.8876399602581774,0,0,2
308,Galanin receptor pathway WP4970,0.5190968042377451,1.2227575602255254,0.8017192043030085,"['CREB1', 'PPARGC1A']",0.8876399602581774,0,0,2
309,ID signaling pathway WP53,0.5190968042377451,1.2227575602255254,0.8017192043030085,"['RB1', 'RBL1']",0.8876399602581774,0,0,2
310,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.5190968042377451,1.2227575602255254,0.8017192043030085,"['TGFB1', 'TLR4']",0.8876399602581774,0,0,2
311,Bladder cancer WP2828,0.5311333340786224,1.0540430503434115,0.6669375072915581,"['RB1', 'DAPK2', 'MAPK1', 'HRAS', 'EGFR']",0.8876399602581774,0,0,5
312,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.5312516835316297,1.5284323770491803,0.966763114401953,['COX8A'],0.8876399602581774,0,0,1
313,FOXP3 in COVID-19 WP5063,0.5312516835316297,1.5284323770491803,0.966763114401953,['STAT5B'],0.8876399602581774,0,0,1
314,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.5312516835316297,1.5284323770491803,0.966763114401953,['ABCB1'],0.8876399602581774,0,0,1
315,Metastatic brain tumor WP2249,0.5312516835316297,1.5284323770491803,0.966763114401953,['CDK6'],0.8876399602581774,0,0,1
316,Mitochondrial fatty acid synthesis pathway WP4317,0.5312516835316297,1.5284323770491803,0.966763114401953,['ACACA'],0.8876399602581774,0,0,1
317,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.5312516835316297,1.5284323770491803,0.966763114401953,['FOXO1'],0.8876399602581774,0,0,1
318,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5312516835316297,1.5284323770491803,0.966763114401953,['EPHA4'],0.8876399602581774,0,0,1
319,Tgif disruption of Shh signaling WP3674,0.5312516835316297,1.5284323770491803,0.966763114401953,['SMAD2'],0.8876399602581774,0,0,1
320,Apoptosis WP254,0.5344116036076915,1.0188614540466392,0.6384073222246178,"['HELLS', 'MAP2K4', 'MAP3K1', 'CRADD', 'TRAF3', 'IRF1', 'CYCS', 'FADD', 'NFKBIE']",0.890129327259061,0,0,9
321,Intraflagellar transport proteins binding to dynein WP4532,0.5382528370480923,1.0631985187498605,0.6585737326537571,"['IFT140', 'WDR60', 'DYNLT3', 'DYNC1I1']",0.8909588886541404,0,0,4
322,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5382528370480923,1.0631985187498605,0.6585737326537571,"['SMAD2', 'TGFB1', 'MAPK1', 'MAP3K5']",0.8909588886541404,0,0,4
323,Canonical and non-canonical Notch signaling WP3845,0.5481678287360285,1.0788235294117647,0.6485604213988224,"['CNTN6', 'ADAM10', 'MAML3']",0.896237585019335,0,0,3
324,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5481678287360285,1.0788235294117647,0.6485604213988224,"['RB1', 'MBD3', 'HDAC1']",0.896237585019335,0,0,3
325,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5481678287360285,1.0788235294117647,0.6485604213988224,"['RB1', 'PRKAA1', 'GOT1']",0.896237585019335,0,0,3
326,Trans-sulfuration and one-carbon metabolism WP2525,0.5481678287360285,1.0788235294117647,0.6485604213988224,"['DNMT3A', 'MAT2B', 'PSPH']",0.896237585019335,0,0,3
327,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.5504090117223964,1.0188323917137476,0.6083383203862492,"['RB1', 'MAP2K3', 'MAP2K4', 'MAPK8', 'EGFR', 'MAP3K5']",0.897149857027637,0,0,6
328,Senescence and Autophagy in Cancer WP615,0.5632018263088323,0.9887471981583571,0.5676568039688056,"['RB1', 'MAP2K3', 'GSK3B', 'TGFB1', 'IRF1', 'ATG10', 'MAPK1', 'AMBRA1', 'SLC39A1', 'HRAS', 'SLC39A3']",0.8980163353842229,0,0,11
329,Cori Cycle WP1946,0.5639209831362417,1.111504589720889,0.6367155542028533,"['PGAM1', 'PFKP']",0.8980163353842229,0,0,2
330,GPR40 Pathway WP3958,0.5639209831362417,1.111504589720889,0.6367155542028533,"['PLCE1', 'PKD1']",0.8980163353842229,0,0,2
331,Major receptors targeted by epinephrine and norepinephrine WP4589,0.5639209831362417,1.111504589720889,0.6367155542028533,"['ADCY9', 'ADCY5']",0.8980163353842229,0,0,2
332,Phytochemical activity on NRF2 transcriptional activation WP3,0.5639209831362417,1.111504589720889,0.6367155542028533,"['MAPK8', 'PRKCA']",0.8980163353842229,0,0,2
333,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5666542490006955,0.9950644135854108,0.5652025089172201,"['MAPK8', 'TBK1', 'TKFC', 'MAP3K1', 'TRAF3', 'FADD', 'MAP3K7']",0.8980163353842229,0,0,7
334,Autophagy WP4923,0.5683965729768434,1.0188130665298443,0.5755640889208776,"['RPTOR', 'PRKAA1', 'ATG9A', 'AMBRA1']",0.8980163353842229,0,0,4
335,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5683965729768434,1.0188130665298443,0.5755640889208776,"['MAPK8', 'TBK1', 'TRAF3', 'MAP3K7']",0.8980163353842229,0,0,4
336,AMP-activated protein kinase (AMPK) signaling WP1403,0.5807976070688028,0.9779331619537275,0.5313628543100974,"['RPTOR', 'PRKAA1', 'RPS6KB1', 'INSR', 'PIK3R3', 'PIK3CB', 'ADIPOR1', 'ACACA']",0.8980163353842229,0,0,8
337,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.5807976070688028,0.9779331619537275,0.5313628543100974,"['CACNB2', 'CACNG7', 'SGCD', 'ITGA8', 'CACNA2D2', 'CACNA1C', 'CACNG2', 'SLC8A1']",0.8980163353842229,0,0,8
338,Regulatory circuits of the STAT3 signaling pathway WP4538,0.5807976070688028,0.9779331619537275,0.5313628543100974,"['RPTOR', 'MAPK8', 'CREBBP', 'STMN1', 'MAPK1', 'LIFR', 'JAK2', 'EGFR']",0.8980163353842229,0,0,8
339,Wnt signaling pathway and pluripotency WP399,0.5808667598711854,0.9743354378423559,0.5292920177828394,"['MAP2K4', 'GSK3B', 'CREBBP', 'APC', 'PPP2R5E', 'PRKCE', 'EP300', 'PRKCA', 'PPP2R5C', 'MAP3K7', 'LRP6']",0.8980163353842229,0,0,11
340,Gastric Cancer Network 1 WP2361,0.5827264891797852,1.0188034188034187,0.5501918948834695,"['APC', 'CEP192', 'GATD3B']",0.8980163353842229,0,0,3
341,Notch Signaling WP268,0.5844871358654312,0.9858746770881632,0.5294349190237396,"['KAT2B', 'CREBBP', 'HDAC1', 'NUMB', 'MAML3']",0.8980163353842229,0,0,5
342,IL-1 signaling pathway WP195,0.5886539609812953,0.9723675604970569,0.5152738774522692,"['MAP2K3', 'MAP2K4', 'MAPK8', 'MAP3K1', 'PELI2', 'MAPK1', 'MAP3K7']",0.8980163353842229,0,0,7
343,Biogenic Amine Synthesis WP550,0.5971787557596614,1.2226434426229509,0.6303201173736037,['GAD1'],0.8980163353842229,0,0,1
344,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.5971787557596614,1.2226434426229509,0.6303201173736037,['HSD11B1'],0.8980163353842229,0,0,1
345,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.5971787557596614,1.2226434426229509,0.6303201173736037,['TCF4'],0.8980163353842229,0,0,1
346,Drug Induction of Bile Acid Pathway WP2289,0.5971787557596614,1.2226434426229509,0.6303201173736037,['ABCB1'],0.8980163353842229,0,0,1
347,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.5971787557596614,1.2226434426229509,0.6303201173736037,['CREB1'],0.8980163353842229,0,0,1
348,Irinotecan pathway WP229,0.5971787557596614,1.2226434426229509,0.6303201173736037,['CYP3A5'],0.8980163353842229,0,0,1
349,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5971787557596614,1.2226434426229509,0.6303201173736037,['MAT2B'],0.8980163353842229,0,0,1
350,Methylation Pathways WP704,0.5971787557596614,1.2226434426229509,0.6303201173736037,['MAT2B'],0.8980163353842229,0,0,1
351,Molybdenum cofactor (Moco) biosynthesis WP4507,0.5971787557596614,1.2226434426229509,0.6303201173736037,['MARC2'],0.8980163353842229,0,0,1
352,PTF1A related regulatory pathway WP4147,0.5971787557596614,1.2226434426229509,0.6303201173736037,['KAT2B'],0.8980163353842229,0,0,1
353,Tamoxifen metabolism WP691,0.5971787557596614,1.2226434426229509,0.6303201173736037,['CYP3A5'],0.8980163353842229,0,0,1
354,Tumor suppressor activity of SMARCB1 WP4204,0.5974110965383578,0.9779784504874295,0.5038054018541849,"['RB1', 'SMARCD3', 'CDK6', 'EED']",0.8980163353842229,0,0,4
355,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5981159457061898,0.9650474414078339,0.4960060652622659,"['GSK3B', 'FYN', 'SOS1', 'CBL', 'MAP3K7', 'PDK1']",0.8980163353842229,0,0,6
356,Hypertrophy Model WP516,0.6056539004381521,1.0187937809670256,0.510870654597288,"['ZEB1', 'ADAM10']",0.8992020304555295,0,0,2
357,IL-9 signaling pathway WP22,0.6056539004381521,1.0187937809670256,0.510870654597288,"['STAT5B', 'MAPK1']",0.8992020304555295,0,0,2
358,Riboflavin and CoQ disorders WP5037,0.6056539004381521,1.0187937809670256,0.510870654597288,"['SLC52A2', 'PDSS2']",0.8992020304555295,0,0,2
359,TP53 network WP1742,0.6056539004381521,1.0187937809670256,0.510870654597288,"['ABL1', 'ATM']",0.8992020304555295,0,0,2
360,Proximal tubule transport WP4917,0.6098903107132423,0.9549858829568788,0.47221774890381085,"['ABCB1', 'SLC20A2', 'SLC4A2', 'ATP1B1', 'ATP6V0C']",0.9013452018837107,0,0,5
361,1q21.1 copy number variation syndrome WP4905,0.6155528207986317,0.9651012145748988,0.4683004239617536,"['TJP1', 'PRKAA1', 'TJP2']",0.9013452018837107,0,0,3
362,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6155528207986317,0.9651012145748988,0.4683004239617536,"['NR3C1', 'JAK2', 'EGFR']",0.9013452018837107,0,0,3
363,Nanoparticle triggered autophagic cell death WP2509,0.6155528207986317,0.9651012145748988,0.4683004239617536,"['INSR', 'ATG10', 'AMBRA1']",0.9013452018837107,0,0,3
364,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6155528207986317,0.9651012145748988,0.4683004239617536,"['GSK3B', 'APC', 'LRP6']",0.9013452018837107,0,0,3
365,Apoptosis Modulation and Signaling WP1772,0.6306413483297757,0.9321249215317012,0.4297263337034624,"['PIDD1', 'MAPK8', 'ENDOG', 'CRADD', 'TRAF3', 'CYCS', 'BIRC6', 'FADD', 'MAP3K5']",0.9051829214641746,0,0,9
366,Integrated Cancer Pathway WP1971,0.6343677761138576,0.9259691369547632,0.42143300372420417,"['ATF1', 'RB1', 'SMAD2', 'ATM', 'MAP3K5']",0.9051829214641746,0,0,5
367,Ciliary landscape WP4352,0.6431403877610091,0.9422963951935914,0.415922322396895,"['RB1', 'HDAC1', 'IFT172', 'TMED1', 'CEP170', 'IFT57', 'CEP290', 'CDR2', 'CREBBP', 'UBE2H', 'RNGTT', 'EXOC8', 'IFT140', 'DYNLT3', 'EXOC6B', 'RANBP9', 'ARMC8', 'COX6C', 'LSM4', 'MYL6', 'IFT88', 'APC', 'WNK1', 'WDR60', 'GLB1', 'EXOC4', 'ARL8B']",0.9051829214641746,0,0,27
368,Cholesterol Biosynthesis Pathway WP197,0.6442783760797044,0.9403461735599101,0.4133991085038601,"['IDI1', 'CYP51A1']",0.9051829214641746,0,0,2
369,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.6442783760797044,0.9403461735599101,0.4133991085038601,"['TRPA1', 'PPARA']",0.9051829214641746,0,0,2
370,Overview of interferons-mediated signaling pathway WP4558,0.6442783760797044,0.9403461735599101,0.4133991085038601,"['PRKCA', 'JAK2']",0.9051829214641746,0,0,2
371,SARS coronavirus and innate immunity WP4912,0.6442783760797044,0.9403461735599101,0.4133991085038601,"['TBK1', 'TRAF3']",0.9051829214641746,0,0,2
372,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6442783760797044,0.9403461735599101,0.4133991085038601,"['ACLY', 'PC']",0.9051829214641746,0,0,2
373,16p11.2 distal deletion syndrome WP4950,0.6465848138035044,0.9167692307692308,0.3997580483497287,"['INSR', 'JAK2', 'SDCCAG8']",0.9051829214641746,0,0,3
374,Cell migration and invasion through p75NTR WP4561,0.6465848138035044,0.9167692307692308,0.3997580483497287,"['TIAM1', 'EFNA3', 'TRIO']",0.9051829214641746,0,0,3
375,Sphingolipid Metabolism (integrated pathway) WP4726,0.6465848138035044,0.9167692307692308,0.3997580483497287,"['CERS5', 'CERS6', 'SGMS1']",0.9051829214641746,0,0,3
376,Biomarkers for urea cycle disorders WP4583,0.6538375699131468,1.0187841530054644,0.4328776399513606,['GOT1'],0.9051829214641746,0,0,1
377,Caloric restriction and aging WP4191,0.6538375699131468,1.0187841530054644,0.4328776399513606,['PPARGC1A'],0.9051829214641746,0,0,1
378,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.6538375699131468,1.0187841530054644,0.4328776399513606,['CYP51A1'],0.9051829214641746,0,0,1
379,Disorders of Folate Metabolism and Transport WP4259,0.6538375699131468,1.0187841530054644,0.4328776399513606,['SLC46A1'],0.9051829214641746,0,0,1
380,Glucuronidation WP698,0.6538375699131468,1.0187841530054644,0.4328776399513606,['PGM5'],0.9051829214641746,0,0,1
381,NAD Biosynthesis II (from tryptophan) WP2485,0.6538375699131468,1.0187841530054644,0.4328776399513606,['HAAO'],0.9051829214641746,0,0,1
382,Pentose Phosphate Metabolism WP134,0.6538375699131468,1.0187841530054644,0.4328776399513606,['RPIA'],0.9051829214641746,0,0,1
383,Serine Metabolism WP4688,0.6538375699131468,1.0187841530054644,0.4328776399513606,['PSPH'],0.9051829214641746,0,0,1
384,Sulfation Biotransformation Reaction WP692,0.6538375699131468,1.0187841530054644,0.4328776399513606,['PAPSS2'],0.9051829214641746,0,0,1
385,Vitamin B12 Disorders WP4271,0.6538375699131468,1.0187841530054644,0.4328776399513606,['CUBN'],0.9051829214641746,0,0,1
386,Endochondral Ossification with Skeletal Dysplasias WP4808,0.6642268439928776,0.8942087263707768,0.36584900700920747,"['STAT5B', 'MEF2C', 'IFT88', 'TGFB1', 'SOX5', 'BMPR1A']",0.9148137153700354,0,0,6
387,Endochondral Ossification WP474,0.6642268439928776,0.8942087263707768,0.36584900700920747,"['STAT5B', 'MEF2C', 'IFT88', 'TGFB1', 'SOX5', 'BMPR1A']",0.9148137153700354,0,0,6
388,Gastric Cancer Network 2 WP2363,0.6757932099775412,0.8730402930402931,0.3421166863747949,"['UBE2T', 'BRIX1', 'EGFR']",0.9173579507182371,0,0,3
389,Photodynamic therapy-induced unfolded protein response WP3613,0.6757932099775412,0.8730402930402931,0.3421166863747949,"['UBE2E1', 'DNAJB9', 'ATF6']",0.9173579507182371,0,0,3
390,Development of ureteric collection system WP5053,0.6770485675227419,0.8729751520926482,0.3404710201262488,"['FRAS1', 'ITGA8', 'RARB', 'ETV4']",0.9173579507182371,0,0,4
391,Prostaglandin Synthesis and Regulation WP98,0.6770485675227419,0.8729751520926482,0.3404710201262488,"['HSD11B1', 'SCGB1A1', 'ANXA6', 'PPARGC1A']",0.9173579507182371,0,0,4
392,BMP Signaling Pathway in Eyelid Development WP3927,0.6798431342095753,0.8731053672109541,0.3369254174631461,"['MAP3K1', 'EGFR']",0.9173579507182371,0,0,2
393,Globo Sphingolipid Metabolism WP1424,0.6798431342095753,0.8731053672109541,0.3369254174631461,"['ST6GALNAC3', 'ST6GALNAC5']",0.9173579507182371,0,0,2
394,"GPCRs, Class B Secretin-like WP334",0.6798431342095753,0.8731053672109541,0.3369254174631461,"['ADGRG2', 'ADGRL2']",0.9173579507182371,0,0,2
395,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6798431342095753,0.8731053672109541,0.3369254174631461,"['TBK1', 'NFKBIE']",0.9173579507182371,0,0,2
396,Nuclear Receptors Meta-Pathway WP2882,0.6939434227916743,0.9157320872274143,0.3345763122519154,"['ABCB1', 'ABHD2', 'SLC2A3', 'AHR', 'NR3C1', 'CYP3A5', 'EGFR', 'FOXO1', 'EPB41L4B', 'SLC39A6', 'EP300', 'PPARGC1A', 'SLC39A1', 'SLC39A3', 'TGFB1', 'NCOA6', 'SLC39A11', 'ARNT', 'SLC39A12', 'SMARCA1', 'SLC6A6', 'KAT2B', 'SLC6A9', 'CDC37', 'PPARA', 'EPHA3', 'FKBP5']",0.9200215337675706,0,0,27
397,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.6942855838028815,0.8727139184722732,0.3184287847875434,"['ACLY', 'IDI1', 'PRKAA1', 'CREB1', 'CYP51A1', 'SEC24D', 'ATF6', 'ACACA']",0.9200215337675706,0,0,8
398,Small cell lung cancer WP4658,0.6944890147952829,0.8840723074421378,0.32231413972873424,"['RB1', 'LAMA5', 'CDK6', 'COL4A2', 'TRAF3', 'RARB', 'PIK3R3', 'CYCS', 'PIK3CB', 'FHIT', 'PTK2']",0.9200215337675706,0,0,11
399,Complement system WP2806,0.7018874379268991,0.8485911476157882,0.30038618903701614,"['LAMA5', 'RPS19', 'GNAI3', 'PRKCA', 'CD59']",0.9200215337675706,0,0,5
400,ATR Signaling WP3875,0.7025305145279572,0.87317037470726,0.3082871571670422,['RAD9A'],0.9200215337675706,0,0,1
401,Bile acids synthesis and enterohepatic circulation  WP4389,0.7025305145279572,0.87317037470726,0.3082871571670422,['MAPK1'],0.9200215337675706,0,0,1
402,Canonical NF-KB pathway WP4562,0.7025305145279572,0.87317037470726,0.3082871571670422,['NFKBIE'],0.9200215337675706,0,0,1
403,"Degradation pathway of sphingolipids, including diseases WP4153",0.7025305145279572,0.87317037470726,0.3082871571670422,['GLB1'],0.9200215337675706,0,0,1
404,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.7025305145279572,0.87317037470726,0.3082871571670422,['UBA3'],0.9200215337675706,0,0,1
405,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.7025305145279572,0.87317037470726,0.3082871571670422,['TIFA'],0.9200215337675706,0,0,1
406,Selective expression of chemokine receptors during T-cell polarization WP4494,0.7025305145279572,0.87317037470726,0.3082871571670422,['TGFB1'],0.9200215337675706,0,0,1
407,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7025305145279572,0.87317037470726,0.3082871571670422,['TGFB1'],0.9200215337675706,0,0,1
408,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7124446275114197,0.8148300017085256,0.2762706263454592,"['MAPK1', 'HRAS']",0.9307181040774184,0,0,2
409,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.7223574747125665,0.825586880515012,0.26850986903301605,"['ABCA1', 'IDI1', 'ELOVL4', 'CYP51A1', 'ACSL4']",0.9413607188797016,0,0,5
410,Tryptophan metabolism WP465,0.7287545077629206,0.796989966555184,0.25218225474836314,"['HAAO', 'HSD17B10', 'CYP2C18']",0.9473808600917968,0,0,3
411,Purinergic signaling WP4900,0.7422126653703173,0.7638390568939005,0.22771529165081297,"['ADORA2A', 'GNAI3']",0.9537330897640064,0,0,2
412,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7430089098222467,0.8281294932682671,0.24599358253321343,"['SMAD2', 'GSK3B', 'MAPK8', 'TBK1', 'TGFB1', 'APC', 'MAPK1', 'CYCS']",0.9537330897640064,0,0,8
413,15q11.2 copy number variation syndrome WP4940,0.7443770456694684,0.7639600409836066,0.2255268030942581,['CYFIP1'],0.9537330897640064,0,0,1
414,Estrogen Receptor Pathway WP2881,0.7443770456694684,0.7639600409836066,0.2255268030942581,['PPARA'],0.9537330897640064,0,0,1
415,Osteoclast Signaling WP12,0.7443770456694684,0.7639600409836066,0.2255268030942581,['MAPK8'],0.9537330897640064,0,0,1
416,Purine metabolism WP4792,0.7443770456694684,0.7639600409836066,0.2255268030942581,['APRT'],0.9537330897640064,0,0,1
417,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7525671870839505,0.7637179487179487,0.21709828359608616,"['LATS1', 'RAP1A', 'FOXO1']",0.9619144141864404,0,0,3
418,Cytosolic DNA-sensing pathway WP4655,0.7602208407257445,0.7831174643289633,0.21468876158364683,"['TBK1', 'POLR1C', 'FADD', 'POLR2K', 'POLR2L']",0.9649021530982875,0,0,5
419,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7650726525054806,0.7635967162647511,0.20447934888423128,"['MAPK8', 'TGFB1', 'COL4A2', 'SOS1']",0.9649021530982875,0,0,4
420,Kallmann's Syndrome WP5074,0.7692991371727096,0.7188470467633491,0.18853588960663634,"['MAPK1', 'GNRH1']",0.9649021530982875,0,0,2
421,Ovarian infertility WP34,0.7692991371727096,0.7188470467633491,0.18853588960663634,"['NCOR1', 'ATM']",0.9649021530982875,0,0,2
422,Statin inhibition of cholesterol production WP430,0.7692991371727096,0.7188470467633491,0.18853588960663634,"['ABCA1', 'APOE']",0.9649021530982875,0,0,2
423,Breast cancer pathway WP4262,0.7702209240790927,0.8378282721030651,0.21873843821541517,"['RB1', 'GSK3B', 'PIK3R3', 'EGFR', 'LRP6', 'FRAT2', 'CDK6', 'RPS6KB1', 'APC', 'MAPK1', 'ATM', 'SOS1', 'HRAS', 'SOS2']",0.9649021530982875,0,0,14
424,Amino Acid metabolism WP3925,0.7723428006358631,0.8008428505204602,0.20687915905780702,"['ACLY', 'PKM', 'PC', 'HIBADH', 'AUH', 'GOT1', 'MARS2', 'ALDH18A1']",0.9649021530982875,0,0,8
425,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7723428006358631,0.8008428505204602,0.20687915905780702,"['GSK3B', 'FRAT2', 'CDK6', 'HNRNPK', 'APC', 'ROR1', 'MAP3K7', 'LRP6']",0.9649021530982875,0,0,8
426,TYROBP causal network in microglia WP3945,0.7746676306465442,0.7331076923076923,0.18717793961396736,"['APBB1IP', 'DPYD', 'ZFP36L2']",0.9649021530982875,0,0,3
427,Cysteine and methionine catabolism WP4504,0.7803393698401591,0.6790186703096539,0.16841453214565402,['GOT1'],0.9649021530982875,0,0,1
428,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.7803393698401591,0.6790186703096539,0.16841453214565402,['MAPK8'],0.9649021530982875,0,0,1
429,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.7803393698401591,0.6790186703096539,0.16841453214565402,['IDI1'],0.9649021530982875,0,0,1
430,Osteopontin Signaling WP1434,0.7803393698401591,0.6790186703096539,0.16841453214565402,['MAPK1'],0.9649021530982875,0,0,1
431,mRNA Processing WP411,0.7934117679297369,0.8246869160181853,0.19084322277078258,"['SRPK2', 'RBM39', 'RNGTT', 'CPSF1', 'SFSWAP', 'CELF2', 'DICER1', 'PTBP2', 'HNRNPK', 'PRPF18', 'CLP1', 'DHX15', 'SREK1', 'CLASRP', 'RBM5']",0.9649021530982875,0,0,15
432,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7938692441668768,0.6788541488695256,0.15670432332973044,"['SESN3', 'ATM']",0.9649021530982875,0,0,2
433,Striated Muscle Contraction Pathway WP383,0.7938692441668768,0.6788541488695256,0.15670432332973044,"['TMOD1', 'MYOM1']",0.9649021530982875,0,0,2
434,Urea cycle and associated pathways WP4595,0.7938692441668768,0.6788541488695256,0.15670432332973044,"['GOT1', 'SLC25A12']",0.9649021530982875,0,0,2
435,Vitamin D Receptor Pathway WP2877,0.7981429754795437,0.7927893002519868,0.1787482455865991,"['CDKN2D', 'ABCB1', 'TGFB1', 'CDKAL1', 'CLPTM1L', 'TRAK1', 'RASGRP1', 'CYP3A5', 'SLC8A1', 'FOXO1']",0.9649021530982875,0,0,10
436,Spinal Cord Injury WP2431,0.7983003409559495,0.7849206349206349,0.17681937380193488,"['RB1', 'EPHA4', 'TGFB1', 'PRB1', 'ROCK2', 'MAPK1', 'PRKCA', 'TLR4', 'EGFR']",0.9649021530982875,0,0,9
437,Genotoxicity pathway WP4286,0.8095115906130508,0.7269971643688277,0.1536320852420421,"['IKBIP', 'TIGAR', 'BRMS1L', 'LRRFIP2', 'PPM1D']",0.9649021530982875,0,0,5
438,22q11.2 copy number variation syndrome WP4657,0.809561424970858,0.782559351782203,0.16532554569791358,"['PRKN', 'NCOR1', 'THAP7', 'DROSHA', 'SHOC2', 'ZDHHC8', 'LZTR1', 'TNPO1', 'CLDN1', 'EGFR']",0.9649021530982875,0,0,10
439,Computational Model of Aerobic Glycolysis WP4629,0.8112445231373714,0.6110655737704918,0.12782621775875322,['PKM'],0.9649021530982875,0,0,1
440,Inflammatory Response Pathway WP453,0.8112445231373714,0.6110655737704918,0.12782621775875322,['LAMA5'],0.9649021530982875,0,0,1
441,"NAD metabolism, sirtuins and aging WP3630",0.8112445231373714,0.6110655737704918,0.12782621775875322,['FOXO1'],0.9649021530982875,0,0,1
442,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.8112445231373714,0.6110655737704918,0.12782621775875322,['ANAPC11'],0.9649021530982875,0,0,1
443,Serotonin and anxiety-related events WP3944,0.8112445231373714,0.6110655737704918,0.12782621775875322,['NLGN1'],0.9649021530982875,0,0,1
444,Folate Metabolism WP176,0.8139976884135627,0.6786894586894587,0.13967276542725457,"['ABCA1', 'SLC46A1', 'INSR']",0.9649021530982875,0,0,3
445,Type II interferon signaling (IFNG) WP619,0.8160947584329077,0.6430710297013678,0.1306879847598288,"['IRF1', 'JAK2']",0.9649021530982875,0,0,2
446,DNA IR-damage and cellular response via ATR WP4016,0.8235495237172886,0.7513070990705952,0.14585244403673148,"['SMARCAL1', 'BRIP1', 'HERC2', 'POLN', 'UIMC1', 'ATM', 'PPM1D', 'RAD9A']",0.9649021530982875,0,0,8
447,7-oxo-C and 7beta-HC pathways WP5064,0.8361489129294446,0.6108662224500256,0.10931362856700909,"['HSD11B1', 'ACOT6']",0.9649021530982875,0,0,2
448,Estrogen signaling pathway WP712,0.8361489129294446,0.6108662224500256,0.10931362856700909,"['CREB1', 'MAPK1']",0.9649021530982875,0,0,2
449,Fluoropyrimidine Activity WP1601,0.8361489129294446,0.6108662224500256,0.10931362856700909,"['DPYD', 'GGH']",0.9649021530982875,0,0,2
450,SARS-CoV-2 mitochondrial interactions WP5038,0.8361489129294446,0.6108662224500256,0.10931362856700909,"['TBK1', 'TRAF3']",0.9649021530982875,0,0,2
451,Signal Transduction of S1P Receptor WP26,0.8361489129294446,0.6108662224500256,0.10931362856700909,"['GNAI3', 'MAPK1']",0.9649021530982875,0,0,2
452,Sphingolipid Metabolism (general overview) WP4725,0.8361489129294446,0.6108662224500256,0.10931362856700909,"['CERS6', 'SGMS1']",0.9649021530982875,0,0,2
453,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8361489129294446,0.6108662224500256,0.10931362856700909,"['P3H2', 'LRP6']",0.9649021530982875,0,0,2
454,Biomarkers for pyrimidine metabolism disorders WP4584,0.8378033514330976,0.5554675856929955,0.0983021374750004,['DPYD'],0.9649021530982875,0,0,1
455,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.8378033514330976,0.5554675856929955,0.0983021374750004,['FOXO1'],0.9649021530982875,0,0,1
456,Dopaminergic Neurogenesis WP2855,0.8378033514330976,0.5554675856929955,0.0983021374750004,['TGFB1'],0.9649021530982875,0,0,1
457,Genes targeted by miRNAs in adipocytes WP1992,0.8378033514330976,0.5554675856929955,0.0983021374750004,['PTBP2'],0.9649021530982875,0,0,1
458,Hedgehog Signaling Pathway Netpath WP47,0.8378033514330976,0.5554675856929955,0.0983021374750004,['SUFU'],0.9649021530982875,0,0,1
459,NO metabolism in cystic fibrosis WP4947,0.8378033514330976,0.5554675856929955,0.0983021374750004,['DDAH1'],0.9649021530982875,0,0,1
460,Overview of nanoparticle effects WP3287,0.8378033514330976,0.5554675856929955,0.0983021374750004,['PTK2'],0.9649021530982875,0,0,1
461,ATM Signaling Network in Development and Disease  WP3878,0.8473518709604304,0.6601306283194431,0.10934353460613228,"['PRKAA1', 'ATM', 'PPM1D', 'MAP3K5']",0.9649021530982875,0,0,4
462,p53 transcriptional gene network WP4963,0.8503676497125912,0.6783595710700433,0.10995292450394342,"['PIDD1', 'TIGAR', 'ERCC5', 'ACAD11', 'CX3CL1']",0.9649021530982875,0,0,5
463,DNA Mismatch Repair WP531,0.8542025972284464,0.5817285396988113,0.0916727856015676,"['POLD4', 'RPA3']",0.9649021530982875,0,0,2
464,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8542025972284464,0.5817285396988113,0.0916727856015676,"['TICAM2', 'TLR4']",0.9649021530982875,0,0,2
465,Eukaryotic Transcription Initiation WP405,0.8605091489423634,0.6427047608760228,0.09655419902433847,"['TAF13', 'POLR2I', 'MNAT1', 'POLR2K']",0.9649021530982875,0,0,4
466,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8605091489423634,0.6427047608760228,0.09655419902433847,"['RPTOR', 'PRKAA1', 'ATG10', 'ACACA']",0.9649021530982875,0,0,4
467,Fatty acid transporters WP5061,0.8606268269679125,0.5091359289617486,0.07641839407198592,['ACSL4'],0.9649021530982875,0,0,1
468,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.8606268269679125,0.5091359289617486,0.07641839407198592,['RB1'],0.9649021530982875,0,0,1
469,Omega-3/Omega-6 FA synthesis WP4723,0.8606268269679125,0.5091359289617486,0.07641839407198592,['ACSL4'],0.9649021530982875,0,0,1
470,Omega-9 FA synthesis WP4724,0.8606268269679125,0.5091359289617486,0.07641839407198592,['ACSL4'],0.9649021530982875,0,0,1
471,Pyrimidine metabolism and related diseases WP4225,0.8606268269679125,0.5091359289617486,0.07641839407198592,['DPYD'],0.9649021530982875,0,0,1
472,Tryptophan catabolism leading to NAD+ production WP4210,0.8606268269679125,0.5091359289617486,0.07641839407198592,['HAAO'],0.9649021530982875,0,0,1
473,Amyotrophic lateral sclerosis (ALS) WP2447,0.8619764919729561,0.6106666666666667,0.09070065909866797,"['PPP3CC', 'ALS2', 'MAP3K5']",0.9649021530982875,0,0,3
474,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8622590109975875,0.6635568252834568,0.09833884059501066,"['LATS1', 'ABL1', 'NABP2', 'ATM', 'RAD9A']",0.9649021530982875,0,0,5
475,NRF2 pathway WP2884,0.8680912752617167,0.7262946351983923,0.1027404872055296,"['SLC6A6', 'TGFB1', 'SLC6A9', 'SLC39A6', 'SLC39A11', 'SLC2A3', 'SLC39A12', 'SLC39A1', 'EPHA3', 'SLC39A3']",0.9649021530982875,0,0,10
476,Ethanol effects on histone modifications WP3996,0.8704215929670067,0.5552397371977075,0.07705483542775048,"['KAT2B', 'HDAC1']",0.9649021530982875,0,0,2
477,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8704215929670067,0.5552397371977075,0.07705483542775048,"['RBL1', 'MAPK1']",0.9649021530982875,0,0,2
478,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.8704215929670067,0.5552397371977075,0.07705483542775048,"['RAB11A', 'DNM2']",0.9649021530982875,0,0,2
479,Monoamine GPCRs WP58,0.8704215929670067,0.5552397371977075,0.07705483542775048,"['DRD1', 'HTR4']",0.9649021530982875,0,0,2
480,Osteoblast differentiation WP4787,0.87922341625324,0.7039411206077872,0.09060865609593909,"['MAPK8', 'BMPR2', 'PRKCE', 'PIK3R3', 'MAPK1', 'PRKCA', 'PIK3CB', 'BMPR1A', 'LRP6']",0.9649021530982875,0,0,9
481,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.8802400740260792,0.46993221941992436,0.059944834610469705,['SYTL2'],0.9649021530982875,0,0,1
482,Differentiation of white and brown adipocyte WP2895,0.8802400740260792,0.46993221941992436,0.059944834610469705,['PPARGC1A'],0.9649021530982875,0,0,1
483,GDNF/RET signaling axis WP4830,0.8802400740260792,0.46993221941992436,0.059944834610469705,['SOX11'],0.9649021530982875,0,0,1
484,Mammalian disorder of sexual development WP4842,0.8802400740260792,0.46993221941992436,0.059944834610469705,['EMX2'],0.9649021530982875,0,0,1
485,Serotonin and anxiety WP3947,0.8802400740260792,0.46993221941992436,0.059944834610469705,['GRM1'],0.9649021530982875,0,0,1
486,Nucleotide Excision Repair WP4753,0.8839307672224249,0.6104669061056952,0.07531729284867399,"['POLD4', 'RPA3', 'ERCC5', 'MNAT1']",0.9649021530982875,0,0,4
487,Glycosylation and related congenital defects WP4521,0.8849646323779663,0.5310543088271343,0.06489887158888347,"['TUSC3', 'ALG3']",0.9649021530982875,0,0,2
488,Wnt signaling in kidney disease WP4150,0.8849646323779663,0.5310543088271343,0.06489887158888347,"['MAPK8', 'LRP6']",0.9649021530982875,0,0,2
489,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8852479415854833,0.6538630860664759,0.07969774555228766,"['PRKN', 'PSMD14', 'FBXW7', 'RNF19A', 'CASK', 'UBE2G1']",0.9649021530982875,0,0,6
490,Eicosanoid Synthesis WP167,0.8970944264839422,0.43632903981264637,0.047382782617227386,['PTGES2'],0.972813945442652,0,0,1
491,PPAR-alpha pathway WP2878,0.8970944264839422,0.43632903981264637,0.047382782617227386,['PPARA'],0.972813945442652,0,0,1
492,Endothelin Pathways WP2197,0.897982103485525,0.5088843328207757,0.054758569969579174,"['MAPK1', 'PRKCA']",0.972813945442652,0,0,2
493,Metapathway biotransformation Phase I and II WP702,0.9112178630354265,0.6775318808257563,0.06299234987108877,"['NAA50', 'CYP2U1', 'CYP4V2', 'NDST3', 'CYP51A1', 'HS6ST1', 'CYP2C18', 'CYP3A5', 'HS6ST2', 'HS6ST3']",0.9795785547249364,0,0,10
494,miRNA targets in ECM and membrane receptors WP2911,0.9115777920141996,0.40720628415300547,0.03769848323088997,['COL4A2'],0.9795785547249364,0,0,1
495,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9115777920141996,0.40720628415300547,0.03769848323088997,['ACSL4'],0.9795785547249364,0,0,1
496,Urea cycle and metabolism of amino groups WP497,0.9115777920141996,0.40720628415300547,0.03769848323088997,['ALDH18A1'],0.9795785547249364,0,0,1
497,Allograft Rejection WP2328,0.918056534112884,0.5232087912087912,0.044732419049489436,"['ABCB1', 'TGFB1', 'HLA-DRA']",0.9810847776393857,0,0,3
498,One-carbon metabolism and related pathways WP3940,0.918056534112884,0.5232087912087912,0.044732419049489436,"['CHDH', 'GAD1', 'DNMT3A']",0.9810847776393857,0,0,3
499,Differentiation Pathway WP2848,0.9199958057978733,0.469660529117218,0.0391631917204382,"['ALK', 'TGFB1']",0.9810847776393857,0,0,2
500,16p11.2 proximal deletion syndrome WP4949,0.923950630387759,0.6000151557250751,0.04745918221742504,"['MAP2K3', 'ASPHD1', 'KMT2C', 'TCP1', 'NR3C1', 'BPTF']",0.9810847776393857,0,0,6
501,Nicotine Activity on Dopaminergic Neurons WP1602,0.9240235616791214,0.38172387295081966,0.030162945534356302,['CHRNB2'],0.9810847776393857,0,0,1
502,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.9240235616791214,0.38172387295081966,0.030162945534356302,['GSK3B'],0.9810847776393857,0,0,1
503,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9347182679351386,0.3592393924783028,0.024252291913868268,['ATG10'],0.9835463172812416,0,0,1
504,Purine metabolism and related disorders WP4224,0.9347182679351386,0.3592393924783028,0.024252291913868268,['APRT'],0.9835463172812416,0,0,1
505,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9347182679351386,0.3592393924783028,0.024252291913868268,['IDH3B'],0.9835463172812416,0,0,1
506,Base Excision Repair WP4752,0.9374777772786079,0.43604012594274,0.028151721005607026,"['POLD4', 'MPG']",0.9835463172812416,0,0,2
507,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9431130342153022,0.5446061894983866,0.031897114480161665,"['GSK3B', 'FRAT2', 'APC', 'ROR1', 'LRP6']",0.9835463172812416,0,0,5
508,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.943908168252419,0.3392531876138434,0.019583864178890957,['FADD'],0.9835463172812416,0,0,1
509,NAD+ biosynthetic pathways WP3645,0.943908168252419,0.3392531876138434,0.019583864178890957,['TNKS'],0.9835463172812416,0,0,1
510,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.943908168252419,0.3392531876138434,0.019583864178890957,['MAPK8'],0.9835463172812416,0,0,1
511,Triacylglyceride synthesis WP325,0.943908168252419,0.3392531876138434,0.019583864178890957,['AGPAT4'],0.9835463172812416,0,0,1
512,Vitamin A and carotenoid metabolism WP716,0.9447949614408926,0.42096891072659465,0.02390570763088015,"['MAPK1', 'RARB']",0.9835463172812416,0,0,2
513,Monoamine Transport WP727,0.9518049034916284,0.3213707937877481,0.015874174151114792,['ADORA2A'],0.9889123071365262,0,0,1
514,Glycerolipids and Glycerophospholipids WP4722,0.95859036161746,0.3052766393442623,0.01291059079850984,['AGPAT4'],0.9901718270195857,0,0,1
515,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.95859036161746,0.3052766393442623,0.01291059079850984,['SOX5'],0.9901718270195857,0,0,1
516,Unfolded protein response WP4925,0.95859036161746,0.3052766393442623,0.01291059079850984,['ATF6'],0.9901718270195857,0,0,1
517,Modulators of TCR signaling and T cell activation WP5072,0.9661544489939913,0.4255813953488372,0.014653436652828283,"['GNA13', 'NDUFB10', 'RASA2']",0.9949102656925238,0,0,3
518,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9694307330309174,0.27747764530551416,0.008614641157513958,['LAMA5'],0.9949102656925238,0,0,1
519,Ferroptosis WP4313,0.9706770317778123,0.3589109657189375,0.01068172154530887,"['SAT2', 'ACSL4']",0.9949102656925238,0,0,2
520,DNA Repair Pathways Full Network WP4946,0.9726745460794541,0.5744860602647142,0.015916560135169473,"['POLD4', 'BRIP1', 'RAP1A', 'CENPX', 'MPG', 'RPA3', 'ATM', 'ERCC5', 'FANCB', 'MNAT1']",0.9949102656925238,0,0,10
521,Glucocorticoid Receptor Pathway WP2880,0.9730792872490467,0.4065982905982906,0.011095950537567728,"['EPB41L4B', 'ABHD2', 'NR3C1']",0.9949102656925238,0,0,3
522,Selenium Micronutrient Network WP15,0.9786450935117867,0.3892307692307692,0.008402021627717407,"['ABCA1', 'INSR', 'SELENOT']",0.9949102656925238,0,0,3
523,Glycerophospholipid Biosynthetic Pathway WP2533,0.9806122113723491,0.2441188524590164,0.004779406956239241,['PIK3CB'],0.9949102656925238,0,0,1
524,Oxysterols derived from cholesterol WP4545,0.9806122113723491,0.2441188524590164,0.004779406956239241,['ACOT6'],0.9949102656925238,0,0,1
525,Neural Crest Differentiation WP2064,0.9831914934262509,0.41321494725674185,0.0070045605736177045,"['GSK3B', 'HDAC1', 'TCF4', 'SOX5']",0.9949102656925238,0,0,4
526,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9856889666081236,0.22599802671523983,0.003257631342206199,['ERBIN'],0.9949102656925238,0,0,1
527,Peptide GPCRs WP24,0.9856889666081236,0.22599802671523983,0.003257631342206199,['ATP8A1'],0.9949102656925238,0,0,1
528,Lung fibrosis WP3624,0.987704754155818,0.21790837236533958,0.0026958442154410623,['TGFB1'],0.9949102656925238,0,0,1
529,"GPCRs, Class A Rhodopsin-like WP455",0.987937842766448,0.4511023607068805,0.00547435062014416,"['RABGAP1', 'OPN3', 'ADORA2A', 'RRH', 'DRD1', 'HTR4']",0.9949102656925238,0,0,6
530,Proteasome Degradation WP183,0.9906831082247063,0.33857549857549857,0.0031692581284023043,"['PSMB6', 'H2AFZ', 'PSMB10']",0.9949102656925238,0,0,3
531,Fatty acid beta-oxidation WP143,0.9922031475294097,0.196770888418826,0.0015402057993155222,['ACSL4'],0.9949102656925238,0,0,1
532,PPAR signaling pathway WP3942,0.9930436423047331,0.27092659035252575,0.0018912480237687072,"['ACSL4', 'PPARA']",0.9949102656925238,0,0,2
533,Translation Factors WP107,0.9995631468964677,0.12180327868852459,5.322176620894906e-05,['EEF1B2'],0.9995631468964677,0,0,1
